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Morphology, pathology and immunology
tnternal heterogeneity of podocyte plasma membrane. Kriz W, Hosser
H, Sahanovic S. Anatornisches Instlliit I der Universiiät Heidelberg.
There is a paucity of methods to demonstrate the topography of
intramembranous components. Orci and coworkers (Lab invest
46:545—553, 1982) applying the fihipin—freeze fracture technique have
found a regular pattern of filipin—cholesterol complexes (diameter 25 to
30 nm) in the luminal podocyte plasma membrane, suggesting the
existence of regularly distributed cholesterol domains within this mem-
brane. We have studied the podocyte plasma membrane of unosmicated
material embedded into a new polyester resin. Tissue samples from rat
kidney, fixed by perfusion with glutaraldehyde, were dehydrated by
either ethanol or acetone, embedded, sectioned, stained by a variety of
procedures and studied by TEM. In specimens dehydrated by ethanol,
a striking internal pattern in the podocyte plasma membrane was
observed. The trilaminar structure of the membrane was regularly
interrupted by gaps, that—in grazing sections—have a diameter of IS to
25 nm. The gaps were separated by a honeycomb pattern of material
that stained most intensively at nodal points. No difference between the
luminal and the abluminal membrane had been found. The slit mem-
brane was anchored to the dark staining moieties of this honeycomb, as
were filamentous structures of the basement membrane. Among the
epithelial cells of the kidney this pattern was unique to the podocyte
membrane. Dehydration by acetone resulted in a smooth podocyte
plasma membrane. These results suggest that ethanol in contrast to
acetone extracts lipids from regularly distributed domains in the mem-
brane.
The permeation and deposition of cationised monomeric, dimeric and
polymeric ferritins in the glomerular basement membrane. Rohrbach R,
Batsford SR. Vogi A. Institutes of Pathology and Immunology,
Freihurg, Federal Republic f Germany. These studies looked at the
influence of the molecular wt of cationised horse spleen ferritin on
movement through the different layers of the GBM. Monomeric,
dimeric and polymeric ferritins were prepared by chromatography on
sepharose 6B and cationised (p1 9 to 9.5). Rats were given I mg/l00 g
body wt i.v. and sacrificed one to 16 hr later. Two to four glomeruli per
rat were examined in the electron microscope. Constant length sections
of the capillary wall were selected and divided into zones referring to
the midpoint of the lamina densa (LD), quantification of the iron cores
was done with a semiautomatic analyzer. Monomeric and dimeric
ferritin molecules could cross the capillary wall when cationised,
polymeric molecules (trimer and larger) were retained by the LD. The
LD did not appear to restrict dimer when compared to monomer.
Dimeric molecules crossed the lamina rara externa (LRE) very slowly
and were rarely seen between foot processes beneath the slit mem-
brane, a region where monomer accumulated preferentially. The larger
dimer molecules had a higher avidity for fixed anionic charges and this
may explain their behaviour in the LRE. The LD seemed to be a
charge—independent barrier with a size cut off (effective molecular
radius) of between 6 nm (dimer, minor axis) and 10 nm (trimer).
Lipoprotein receptor activity in cultured epithelial cells of the human
glomerulus. Gröne H—J, Wa/li A, Grñne E, Helmehen U, Seidel 1).
University of Gnttingen, Department of Pathology and Clinical ('hem-
istrv, Göttingen. West Germany. Various pathological disorders are
accompanied by a deposition of lipids in glomeruli. In the rare genetic
disease of lecithin—cholesterol—acyl-transferase deficiency (LCAT), ac-
cumulation of lipids in glomeruli is observed and leads to kidney failure.
In order to gain an insight into these disorders, it is essential to know if
glomerular cells possess lipoprotein receptors. The aim of this study
was to characterize the activity of lipoprotein receptors in cultured
epithelial cells of the human glomerulus. Isolated human glomeruli
(purity > 95%) were incubated in buffered RPMI 1640 medium,
supplemented with 20% heat—inactivated fetal bovine serum at 37°C and
5% CO2. Outgrowing cells were vimentin— and keratin—positive; they
were used for lipoprotein receptor activity experiments seven to nine
days after first subculture and two days after stimulation of lipoprotein
receptors with lipoprotein deficient medium. Isolation, characterization
and determination of binding, internalization and degradation of '25l-
labeled lipoproteins were performed. Human glomerular epithelial cells
had low LDL receptor activity as compared to human fibroblasts.
Binding, internalization and degradation were specific for homologous
LDL and saturable. Apo E containing lipoproteins (chylomicron rem-
nants, VLDL, VLDL-LCAT) as well as apo E containing HDL
fraction of LCAT plasma were taken up rapidly by the glomerular cells.
At a concentration of 5 ,zg 251 lipoprotein. the specific amount of
degraded lipoprotein (ng/mg cell protein) was: LDL 173 29, VLDL
270 19, VLDL-LCAT 560 22, HDL-LCAT 506 30. The
experiments show that human glomerular cells have lipoprotein recep-
tor activity for apo B and apo E. Lipoproteins with apo E are taken up
with great avidity. Plasma concentrations of apo E containing
lipoproteins are increased in certain renal diseases: these lipoproteins
could be rapidly taken up by glomerular cells and lead to lipid
deposition in glomeruli.
Target antigens of antiglomerular basement membrane antibodies—
identification by "western—blot" technique. Weher M, Manns M. Kur:
P. Meyer zum Busehenfelde K—H, Kdhler H. First Department of
Internal Medicine, University of Mainz, Federal Republic of Ger,nanv.
In patients with Goodpasture (GP) syndrome a linear deposition of IgG
along the glomerular basement membrane (GBM) as well as circulating
antiglomerular basement membrane antibodies (anti-GBM-AB) can be
demonstrated. The target antigens of the anti-GBM-AB, however, have
not yet been entirely characterized. It was the aim of our investigation
to characterize the target antigens by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and "western—blotting". GBM. digested by
collagenase, pepsin or trypsin was used as antigen preparation. SDS-
PAGE (5 to 20%) was performed to separate the basement membrane
components. The GBM components were then blotted Onto nitrocellu-
lose paper, incubated with different sera, and hound IgG was detected
by immunoperoxidase staining. Sera from patients with floride GP
syndrome and anti-GBM-AB (4). one serum from a patient with GP
syndrome in clinical remission and no anti-GBM-AB as well as sera
from patients with various forms of glomerulonephritis (16), SLE (12),
autoimmune chronic active hepatitis (10) and from healthy blood donors
(10) were investigated. Reactivities on nitrocellulose sheets were ob-
tained only when collagenase—solubilized GI3M was used as antigen
source. Three GP sera with high titers of anti-GBM-AB and the lgG
fraction of one GP serum eluted from protein A-sepharose 4B identified
components with the mole wt 23.500, 24.500. 41 .000 and 46.000 as
target antigens. The fourth GP serum with a low titer of anti-GBM-AB
did react only with the component of 24.500 D. The control sera and the
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serum of one GP patient in clinical remission were negative. In addition,
no reactivities with positive sera were obtained, when pepsin— or
trypsin—digested GBM was used. Reduction with 2-mercaptoethanol
destroyed the GP target antigens as demonstrated by negative im-
munoblot and ELISA. We conclude that anti-GBM-AB may recognize
at least antigens of four different mole wt in a collagenase digest of
human GBM as target antigens, and that the antigens are sensitive to
reduction. The different reactivity of the fourth serum might be due to
a low titer, a low avidity or a heterogeneity of the anti-GBM-AB.
Further investigations should clarify the precise nature of the GP target
antigens.
Microheterogeneity of antigens in human anti-glomerular basement
membrane nephritis demonstrated by 2D-SDS page immunoblotting.
Wingen A—M, Rauterberg EW. Institute of Immunology, University of
Heidelberg, Federal Republic of Germany. Recently we demonstrated
by immunoblotting that serum autoantibodies of patients with anti-
glomerular basement membrane nephritis (A-GBM-N) reacted with a
uniform pattern with peptides released from GBM upon digestion with
collagenase (C-GBM) or trypsin (T-GBM) (mole wt: 50, 43, 29-26kD).
According to Wiesländer et al (Proc Nail Acad Sci 8 1:3838, 1984) the
reactive peptides are suggested to be part of the noncollagenous,
globular NCI domain of type IV collagen. In the present study, we
characterized the peptides extractable with collagenase and trypsin by
their isoelectric points (p1), mole wts and their reactivity with seven
sera of patients with A-GBM-N by two dimensional SDS polyacrylam-
ide gel electrophoresis followed by immunoblotting. Irrespective of the
source of the peptides, that is, individual versus pooled human kidneys,
we found a constantly reproducible pattern of heterogeneity within
either C- or T-GBM. In 2D SDS PAGE stained with Coomassie brilliant
blue the majority of the 50,43 and 29-26kD peptides of C-GBM resolved
into four to six spots, each between p1 8.3 to 7.0, and the corresponding
bands of T-GBM into three spots, each between p1 7.9 and 7.2.
Immunoblotting revealed a rather similar pattern of reactivity of the
seven different patients' sera with all of the protein spots. In C-GBM we
found a relatively stronger reactivity with the most cationic components
up to p1 8.7, while in T-GBM the reactivity was analogous to the
respective protein content. In conclusion, this may indicate that trypsin
and collagenase have different cleavage points near to the (presumably
N-terminal) region producing the charge heterogeneity of NCI-related
peptides. The antigenic epitopes recognized by the sera of patients with
A-GBM-N seem to be not a part of, but near to the peptide regions
bearing the heterogeneity of charge.
C3d deposits as a marker of local complement activation in "C3"-
positive and -negative kidney biopsy specimen in various forms of
glomerulonephritis. Rauterberg EW, Win gen AM, Ritz E. Institute of
Immunology and Serology, Department of Immunopathology, and
Internal Medicine, University of Heidelberg, Federal Republic of
Germany. Local complement activation induced by tissue bound immu-
noglobulins (Ig) or immune complexes (IC) is assumed to be involved in
the pathogenesis of various types of human glomerulonephritis (GN). In
a substantial number of kidney biopsy specimens, immunopathological
staining with anti-"C3" reveals negative results or deposition patterns
different from those of Ig or IC. Since "C3" deposits mainly consist in
C3b which upon activation is able to bind covalently to tissue structures
and since such C3b can rapidly be cleaved (by the factors I and H or
CR-I) to C3d or C3d-g, lack of "C3" staining may reflect the inability
of the majority of commercially available antibodies against "C3" to
react with C3d and C3d-g. In the present study, we compared the
immunohistological results after indirect staining with anti-C3c and
anti-C3d with regard to patterns and intensities in 23 specimen with
IgA-GN, 19 with membranous GN (MGN), 6 with anti-glomerular
basement membrane GN (AGBM-GN) and 13 with minimal change GN
(MCGN). The antibodies were used at comparable antibody concentra-
tions as tested by chess board titration with C3b- or C3d-coated
sepharose beads. Reactivity with anti-C3c was assumed to reflect tissue
bound C3b or iC3b. Tissue bound C3d was mainly not acid elutable. In
all C3b-positive specimens the C3d staining revealed stronger signals,
and there were more often deposits along the peripheral glomerular
basement membrane (PGBM) than C3b: (1) MGN—granular C3d along
the PGBM: 16/19 (C3b: 12/19), (2) IgA-GN—granular C3d spreading
into parts of PGBM: 15/23 (C3b: 4/23), (3) one case of AGBM-GN
without C3b deposits and 2/6 with granular global C3b staining revealed
as well as the other three cases (with linear C3b staining along the
PGBM) a linear pattern with anti-C3d corresponding to the anti-lgG
staining. In MCGN mesangial or segmental C3d deposits with marked
intensity were observed in 11/13 biopsies (C3b: weak granular staining
in 5/13 cases) even in the absence of IF-detectable 1g. Our findings
suggest that C3d seems to be a better marker than C3b for complement
activation in the tissue. Since it was not acid elutable, C3d seems to be
covalently bound and may rather reflect local complement activation
than deposition of C3d-bearing preformed IC.
Association of minimal change glomerulonephritis (MCGN) with HLA-
DR7 and -MT3. Muller GA, Gebhardi M, Risler T, Bohie A. Medical
University Clinics, Dept. 3, and Institute of Pathology, University of
Tubingen, 7400 Tubingen, Federal Republic of Germany. In children,
minimal change glomerulonephritis (MCGN) is the main cause of a
nephrotic syndrome with a rather good prognosis. In adults, however,
MCGN may sometimes develop into focal sclerosing glomerulonephri-
tis (FSGN) as documented by several rebiopsies. The present study was
undertaken to proof whether there is a common genetic marker for both
diseases. Twenty—seven patients (mean age 31 yrs) with MCGN and a
nephrotic syndrome, and 34 patients with FSGN (mean age 44 yrs) were
investigated. All patients underwent diagnostic renal biopsy. Of all
patients HLA-ABC, -DR, -DQ, -MT antigens were determined on
peripheral blood lymphocytes using the well characterised antisera of
the 9th International Histocompatibility Workshop. Antigen frequen-
cies of each patient group were compared with their occurrence in the
local panel group of 186 healthy blood donors and the relative risk (RR)
for disease susceptibility was calculated. Statistical analysis was done
by chi square tests. In patients with MCGN a significant increase for the
HLA-class II antigens HLA-DR7 and -MT3 was observed compared to
their frequency in the local control group. 67% patients with MCGN
carried the antigen HLA-MT3 (rr = 7.1; P < 0.01) and 44% typed
positive for HLA-DR7 (rr = 4.5; P <0.01). In contrast, in patients with
FSGN a normal frequency of these HLA-speciflcities was observed.
24% of these patients revealed an elevation of the HLA-C locus antigen
HLA-Cwl(rr = 5.1; P <0.01). A slight increase of this specificity was
observed in patients with MCGN. All other HLA-antigens showed a
normal distribution in both patient groups. Thus association with
HLA-DR7 and HLA-MT3 indicates a genetic predisposition for
MCGN. Furthermore these results suggest that FSGN not associated
with MHC antigens in adults probably does not develop from MCGN.
Role of lymphocytes in experimental in situ immune complex glomer-
ulonephritis (ICGN) in rats. Thaiss F, Mihatsch MJ, Batsford 5, Vogt
A, Schollmeyer P. Medizinische Universit/itsklinik, Zentrum fur Hy-
giene, Freiburg und Pat hologisches Instilut, Basel, Germany. In in situ
ICGN in the rat complement, polymorphonuclear granulocytes and
monocytes contribute to glomerular injury. The role of lymphocytes has
not yet been established. The effect of Cyclosporin A (CyA) on the
course of in situ ICGN was studied. For inducing nephritis, the left
renal artery of male Wistar rats was perfused with cationized human-
IgG followed by intravenous injection of rabbit—anti-human-IgG. CyA
was given orally twice daily in the following doses: 2.5, 10, 15 and 25
mg/ 2 g body wt. Application of CyA was without influence on
differential blood count and serum C3 level. The amount of immune
complexes deposited in the left kidney was not diminished by CyA
application compared to control nephritic kidneys as shown by exper-
iments with radiolabeled antibody injected intravenously. Furthermore
CyA application was without influence on immunofluorescent micro-
scopic findings and histological examinations. Nevertheless proteinuria
was significantly reduced in CyA-treated animals (< 50 mg/ 24 hr
compared to 350 mgI 24 hr in control nephritic rats). The results show
that CyA does not inhibit glomerular proliferation after inducing in situ
ICGN, however it significantly inhibits proteinuria. Thus CyA inter-
rupts cellular interactions which might lead to glomerular basement
membrane damage. As activation and proliferation of lymphocytes is
suppressed by CyA, lymphocytes play an important role in the patho-
genesis of in situ ICGN in rats. In in situ ICGN in rats it was shown for
the first time that four different mediators—complement, polymorpho-
nuclear granulocytes, monocytes and lymphocytes—cooperate in in-
ducing nephritis.
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increased thromboxane B2 formation by glomeruli from rat kidneys
after induction of in situ immune complex glomerulonephritis (ICGN).
Thaiss F, HeI,nclien U, Kudelka S, Scholl,never P, Stahl RA. Univer-
sity of Freiburg and Gottingen, Federal Republic of Germany. Glomer-
ular in vitro prostaglandin E2 (PGE2) and thromboxane B2 (TxB2)
production (pg/mg protein/mm) were measured 2, 24, 48 hr and seven
days after induction of in situ ICGN. For inducing nephritis, the left
kidneys of male Wistar rats were selectively perfused with cationized
human-IgG by a PP1O polyethylene catheter advanced from the left
carotic artery into the left renal artery. The rabbit anti-human—IgG-
antibody was given intravenously after circulation restored. Right
kidneys served as controls (C). Glomerular TxB2 biosynthesis was
significantly increased 2 and 24 hr after inducing ICGN compared to
control kidneys. No difference in glomerular TxB2 biosynthesis was
seen two and seven days after inducing ICGN. POE2 production of
isolated glomeruli of nephritic kidneys was not different compared to
control kidneys at 2, 24 and 48 hr after inducing nephritis. On day 7, in
vitro glomerular POE2 production was increased in ICON, however, it
was not significantly different from control kidneys.
Two hr after induction of ICON, GFR of nephritic kidneys was
TxB, POE2
Time ICGN C ICGN C
2 hr 448 116 238 29 372 34 295 30
24hr 78 7 75 II 92 4 147 12
48 hr 32 3 47 13 144 14 164 17
7days 122 28 166 26 242 31_—
171±13
significantly lower (164 38 piiter/min/l00 g body wt) compared to
control kidneys (295 82 jditer/min/100 g body wt). Pretreating
animals with an TxB2 biosynthesis inhibitor (UK38485) prevented
reduction of GFR in nephritic kidneys and depressed glomerular TxB2
biosynthesis. Chronic application of UK38485 (one week) significantly
inhibited TxB2 biosynthesis in vitro concomitant with a significant
increase of glomerular POE2 production. These results show that
arachidonic acid metabolites might have pathogenetic implications in
regulation of glomerular hemodynamics in in situ ICGN.
Subtypes of acute postinfectious glomerulonephritis. Pathological—clini-
cal correlations and follow—up studies. Sorger K, Thoenes W. Depart-
ment of Pathology, University of Mainz, Mainz, Federal Republic of
Germany. Although acute postinfectious glomerulonephritis (APGN)
today is considered one of the best defined renal diseases, still a number
of questions remain to be elucidated. For instance, there are no criteria
which allow more reliable prognostication of the disease. We have,
therefore, studied systematically a large collection of renal biopsies
obtained from children and adults (100 cases) at an early stage (up to 9
weeks) and also at later stages (8 second biopsies, up to four years after
onset of their renal disease) and have correlated our morphological
results with clinical findings, age of the patients and course of their
disease (up to 10 years after onset of the illness). Based on 58 cases (42
male, 16 female patients; 27 children and 31 adults) whose biopsies were
uniformly examined by using the diagnostic triad of light, im-
munofluorescence, and electron microscopy, the main morphological
features of APGN subtypes were established, revealing three different
patterns: starry sky, mesangial and garland patterns, which have
previously been reported. The garland pattern is of particular signifi-
cance, morphologically because immunocomplexes are predominantly
located subepithelially, as well as clinically because most of the patients
have considerable proteinuria. The most reliable clinical parameter
revealed by our follow—up studies (up to 10 years) was proteinuria.
Comparing the three groups, it becomes apparent that proteinuria in
patients afflicted with the starry sky and mesangial patterns commonly
subsides rather quickly. Patients with the garland pattern may show
complete disappearance of their proteinuria—especially when they are
younger—others, however, may display a significant proteinuria over
months to years after the onset of their illness, indicating a protracted,
respectively chronic course. The morphological findings of the second
biopsies correlate with the clinical findings. Biopsies of patients whose
proteinuria disappeared, histologically disclosed only minimal residual
findings consisting of mild mesangial hypercellularity. Patients with a
protracted and chronic course of their disease developed persistent
proliferation of mesangial cells, fibrous crescents and scarring of their
glomeruli. The three subtypes are, therefore, important to prognosti-
cate APON. the course of which usually is favorable when the starry
sky and mesangial patterns are present but is more unfavorable when
the garland type is encountered.
The significance of non immunological mechanisms in the progression
of glomerulonephritides. Biwer E, Christensen J, Bohie A. Institute of
Pathology, University of Tübingen, The Gade Institute, University of
Bergen, Norway. Since it has been pointed out that dietetic factors play
an important role in the progression of various glomerulonephritides,
we were interested in the question whether other non-immunological
processes influence the course of glomerulonephritides. in particular
we wanted to find out whether glomerulonephritides can be complicated
by decompensated benign nephrosclerosis, a disease accompanied by
progressive renal failure. The results of these investigations are follow-
ing: all types of glomerulonephritis, except the rapid progressive
glomerulonephritis can be influenced by the appearance of decompen-
sated benign nephrosclerosis. The decompensated benign nephroscle-
rosis is most frequently accompanied by mesangioproliferative glomer-
ulonephritis. A focal sclerosis, a perimembranous or membranoprolif-
erative glomerulonephritis are more seldom complicated by a grafted—
on decompensated benign nephrosclerosis. A decompensated benign
nephrosclerosis develops only when the glomerulonephritis is showing
a clinically malign hypertonus. in advanced stages of these
glomerulonephritides the glomerular lesions caused by hypertonus may
stand in the foreground of the pathological changes. These changes can
be immunologically marked off by the named glomerulonephritides
through a focal and segmental staining of 1gM and C3 and through a
special pattern of lesions on PAS-slides associated to no glomerulone-
phritis. Until now investigations of 30 cases showed that the ratio
between male and female is about 5 to I in glomerulonephritides
complicated by a decompensated benign nephrosclerosis as like in
idiopathic decompensated benign nephrosclerosis.
Degradation of diabetic and nondiabetic basement membrane caused
by isolated glomeruli. Hasslacher Ch, Knecht R, Leher R. Medical
University Clinic, Heidelberg, Federal Republic of Germany. The
increase of basement membrane (b.m.) material in glomerular capillar-
ies and mesangium seems to be an important factor of the pathogenesis
of diabetic nephropathy. Beside an increased synthesis, an impairment
of b.m. breakdown has been demonstrated as a cause. However, it is
now known whether the reduced degradation of b.m. peptides is due to
an impaired activity of glomerular proteolytic enzymes, or if it is the
consequence of a reduced susceptibility of b.m. to proteolysis. We
investigated the degradation of diabetic and nondiabetic b.m. caused by
isolated glomeruli of diabetic and nondiabetic rats as follows: isolated
b.m. were incubated with an homogenate solution of glomeruli for 36
hours at 37°C. The reaction was terminated by adding TCA. After
centrifugation, the supernatant, which contained peptides produced
from the substrate, and the pellet containing undigested b.m. were
lyophilized and hydrolyzed. The concentrations of amino acids
(collagen typical: hydroxyproline, hydroxylysine, glycmne; non-collagen
typical: proline, lysine, leucin) were determined in both fractions by an
amino acid analyzer. The relative amounts of amino acids released in
the supernatant fraction, as compared with the total content of b.m.,
served as a parameter of b.m. degradation. Results: compared to
nondiabetic b.m., the degradation of diabetic b.m. caused by glomeruli
of metabolically healthy rats was on average 40% lower (P < 0.05).
B.m. of rats with longer duration of diabetes (10 to 12 weeks) were
much less susceptible to proteolytic attacks than those of rats with a
shorter duration of diabetes (4 to 6 weeks). When b.m. of normal rats
were incubated with diabetic or nondiabetic homogenate, the release of
collagen typical amino acids was slightly elevated in diabetes. The
results indicate that the prolonged turnover of b.m. in diabetes seems to
be caused by a reduced susceptibility of diabetic b.m. to proteolytic
enzymes. This may he a consequence of the increased nonenzymatical
glycosylation or of other physicochemical alterations which have been
described in diabetic b.m.
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Physiology and pathophysiology
Regulation of potassium conductance in MDCK—cells. Paulmichl M,
Defregger M, Lang F. Department for Physiology, University of
Jnnsbruck, Austria. According to electrophysiological studies in this
laboratory, the plasma membrane of cultured Madin—Darby—canine—
kidney (MDCK) cells is highly conductive to potassium. The present
study has been designed to disclose factors regulating this potassium
conductance (Gk). To this end, the potential difference across the
plasma membrane (V) has been determined continuously during rapid
(within I sec) changes of extracellular perfusates utilizing conventional
microelectrodes (filled with I mole/liter KCI, resistance 100 to 200 MC1,
tip potential < 5 mV). Gk was evidenced from the cell membrane
depolarization (dVk) following step increases of extracellular potassium
concentration from 5.4 to 20 mmole/liter. The composition of control
extracellular perfusate was in mmole/liter: 114 NaCI, 16 NaHCO3, 5.4
KCI, 0.8 MgCI2, 1.2 CaCI2, 1.0 Na,HPO4INaH,P04 (95% air, 5% C02,
pH 7.4, 37°C). Under control conditions V amounts to —51.0 0.5 mV
(N = 122) and dVk to 17.0 0.4 mV (N = 85). One mmole/liter barium
depolarizes V to —31.7 0.4 mV (N = 34) and reverses dVk to —1.2
0.3 mV (N = II) Ten mole/liter valinomycin hyperpolarizes V to
—69.3 2.9 mV (N = 7) and increases dVk to 31.0 1.0 mV (N
7), even in the presence of 1 mmole/liter barium. Reduction of extra-
cellular pH to 7.3 (constant pCO2) depolarizes V to —43.7 1.8 mV (N
= 8) and reduces dVk to 11.9 0.9 mV (N = 8). Alcalosis hyperpolar-
izes V and increases dVk. Complete removal of bicarbonate and CO2 at
constant extracellular pH hyperpolarizes V to —60.4 0.9 mV (N =
14) and increases dVk to 22.0 1.8 mV (N = 14). Reduction of
extracellular sodium concentration from 133 to 19 mmole/liter
hyperpolarizes V to —63.1 0.9 mV and increases dVk (N = 14). This
effect is abolished by simultaneous reduction of extracellular calcium.
0.01 smole/1iter epinephrine hyperpolarizes V to —71.5 1.0 mV (N
= 14) and increases dVk to 30.6 0.2 mV (N = 5). This effect of
epinephrine is abolished by phentolamine and is blunted by calcium
channel blocking agents (nifedipine, verapamil). I mmole/liter ouabain
leads to a depolarization of V paralleled by a similar decline of dVk. In
conclusion, the potassium conductance in MDCK cells can be blocked
by barium, can be reduced by acidosis and calcium channel blocking
agents as well as inhibition of sodium/potassium-ATPase, and can be
stimulated by intracellular alcalosis, reduction of extracellular sodium
activity and epinephrine (via a-receptors). The effects of reduced
extracellular sodium activity and epinephrine are most likely mediated
by increases of intracellular calcium activity.
Adaptation to chronic potassium loading in normal man. Hené Ri,
Koomans HA, Boer P, Dorhout Mees EJ. Department of Nephrology
and Hypertension, University Hospital, Utrecht, The Netherlands. To
analyze factors involved in the maintenance of potassium balance
during increased intake, six healthy males were studied on a normal (80
mEq) and high (300 mEq) potassium diet. After 18 days of a potas-
sium—rich diet, urinary potassium excretion (UK) had increased (Ta-
ble). Plasma renin activity (PRA), and body weight (BW) were un-
changed, serum potassium (sK) and plasma aldosterone (PAC) some-
what increased at 12.00 hr, and the ratio of plasma aldosterone to renin
activity consistently elevated.
sK
mmole/liter
PRA PAC
fmole/l/sec pmole/liter
control
high K
4.07 0.27
4.48 0.29
360 190
320 160
145
270
92
120
UNa
mmole/24
hr
UK
mmole/24 hr
BW
kg
control
high K
162 20
169 28
50 12
233 45
70
70
7
7
Acetazolamide injection (I g i.v.) gave increases in sodium and potas-
sium excretion rates which were similar on the two diets, indicating that
a sudden increase in distal solute delivery was not handled differently
after potassium loading. The reaction to a high dose aldosterone (I mg
iv. followed by 0.5 mg/hr infusion) in terms of sodium retention and
potassium excretion was also comparable, indicating no altered sensi-
tivity to aldosterone after adaptation to the potassium—rich diet. By
contrast, the aldosterone antagonist canrenoate (100 mg iv.) acutely
raised NaCI excretion without changing potassium excretion during the
high potassium diet, but did not affect NaCI excretion during the normal
diet. Subsequent oral administration of spironolactone for five days (200
mg daily) caused a more negative sodium balance associated with more
wt loss and rise in renin activity during the potassium—rich diet.
Surprisingly, we noticed no fall in renal potassium excretion in this
period, but serum potassium was raised by 0.3 to 0.4 mEq/liter at the
end. We conclude that adaptation of a healthy subject to a potas-
sium—rich diet does not involve intrinsic changes of the distal tubule,
but a shift of sodium reabsorption from a proximal to a distal
(aldosterone—sensitive) nephron level. A concomitant rise in aldoster-
one facilitates potassium excretion and, in particular, prevents a lasting
loss of sodium. Slight rises in plasma potassium may play a key role in
mediating both this change in renal sodium handling and aldosterone
release.
Extra- and intracellular electrolyte concentrations of the renal cortex
under potassium adaptation. Beck F, Dorge A, Schramm M, Thurau K.
Physiologisches Institut der Universität, Pettenkoferstr. 12, D-8000
Mdnchen 2, Federal Republic of Germany. Chronic alterations in
potassium intake are well known to cause sustained changes in trans-
port properties of distal tubular cells, the main regulatory site of renal
K excretion. Since distal K secretion is thought to be linked to cellular
K concentration, electrolyte concentrations of the various distal cell
types were measured in control and K-adapted rats. To assess apical
and basolateral transmembrane electrolyte gradients, electrolytes were
also determined in the plasma and early and late distal tubular fluid.
Analyses were performed on I s thick, freeze—dried cryosections and
on freeze—dried samples of tubular fluid using energy—dispersive x-ray
analysis. Chronic K-loading was achieved by feeding a high-K diet for
at least eight days which led to a threefold increase in fractional K
excretion. In control animals, K in early distal tubular fluid was (mean
SEM) 3.6 0.3 mri and 135 3 mmole/kg wet wt (w.w.) in the early
distal tubular cells. In K-adapted animals the values were 4.4 m and
144 2 mmole/kg w.w., respectively. Na concentrations of 44 4mM
and 12 I mmole/kg w.w. were found under control conditions in the
tubular fluid and in the cells of this nephron segment, while in K-loaded
animals concentrations of 58 3 mi and 8 I mmole/kg w.w. were
measured. K concentration was 13.4 1.6 m in the fluid of the late
distal tubule and 138 4 mmole/kg w.w. in the principal cells of the
cortical collecting tubule in controls, whilst in K-loaded rats concen-
trations of 27.1 3.3 msi and 144 3 mmole/kg w.w. were obtained.
Na concentration was found to be decreased in both tubular fluid (from
34 5 to 20 4mM) and principal cells (from II Ito 4 I
mmole/kg w.w.) following chronic K-loading. No significant changes in
cellular Na concentration could be observed in proximal tubular or
intercalated cells. The small increase in cell K concentrations during K
adaptation would seem insufficient to explain the marked rise in renal K
excretion. The fall in Na concentrations observed in the cells of the
distal convolution and in the principal cells of K-loaded animals despite
elevated luminal Na concentrations in the early distal tubule may
indicate an increased activity of the Na-K-ATPase caused by chronic
increase of K intake.
Membrane properties of fused renal epithelial cells of distal amphibian
nephron. Oberleithner H, Schmidt B, Dietl P. Department of Physiol-
ogy, University of Wurzburg, Federal Republic of Germany. Measure-
ments of cell membrane potentials and intracellular ion activities by
microelectrodes in renal tubule cells in vivo allow the characterization
of transepithelial transport at cellular level. However, the feasibility of
the intracellular measurements is markedly reduced by the small cell
size, and the interpretation of the measurements is difficult due to the
presence of the paracellular shunt—pathways. To circumvent these
problems, we isolated cells (diameter 10 m) of the early distal nephron
of rana pipiens, perfusing the kidneys with collagenase—containing and
Ca2-free solutions, and fused the single cells to "giant epithelial cells"
by a modified polyethylene—glycol method. After a four hr incubation
period in serum—free culture, medium cells were superfused in a rapid
sequence with solutions of various ion composition. Intracellular p0-
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tential measurements with KCI-microelectrodes were performed while
interference—contrast microscopy was applied. The mean cell mem-
brane potential (Vm) of these giant cells was 52 3 mV (N = 30). The
cell membrane hyperpolarized after application of furosemide (5 l0-
mole/liter) for 10 2 mV. K-concentration step—changes (3 to 15
mmole/liter) and C1 step—changes (105 mmole/liter to 60 mmole/liter)
depolarized the cell membrane by 14 3 my and 9 2 mV,
respectively. The K-induced voltage changes were completely
inhibitable by Ba2 (3 mmole/liter). Conclusions: (I) Early distal renal
epithelial cells retain their specific membrane properties despite fusion.
(2)The cell membrane is permeable for K and C1 at a ratio of 1:2. (3)
The furosemide—induced hyperpolarization is explained by a new
transmembrane C1-equilibrium potential after inhibition of the
Na/K/Cl cotransport system.
Aldosterone induces chloride transport in the cortical collecting tubule
(CCT). Nasemann J, Horster MF. institute of Physiology, University of
Mflnchen, Federal Republic of Germany. Ion transport in the CCT is
dependent upon aldosterone plasma concentration. The ontogenetic
differentiation of net chloride transport (J°°1) and its induction by
aldosterone were studied by in vitro perfusion of rabbit CCT. Experi-
ments were performed at 37°C in four groups (I—IV): I, ISO to 280 g of
body wt (bw); 11, 330 to 480 g; III, 530 to 880 g; IV, 980—1610g. In each
group, aldosterone (100 g/l00 g bw/day) was given subcutaneously in
three doses daily for six days (IA—IVA).
Conclusions: transepithelial net chloride flux increases with CCT dif-
ferentiation and is induced by aldosterone. The inducing action de-
creases with natural differentiation. Aldosterone—induced J°' chloride
is similar in all phases of differentiation. Aldosterone suffices to induce
the complete expression of J"°' chloride in the cortical collecting tubule.
Electrical properties of collecting duct principal cells in cell culture.
GrossP, Minuth W, Kriz W, Främter E. Medizin Klinik, Anatomisches
Institut, University of Heidelberg, Heidelberg; Zentrum der
Physiologie, University of Frankfurt, Frankfurt, Federal Republic of
Germany. In vivo collecting duct epithelium consists of two different
cell types, principal cells and intercalated cells. In the past it has not
been possible to study both cell types separately. Utilizing cell culture
methods, we successfully grew a new epithelium in primary cell culture
that is derived from collecting duct ampulla of newborn rabbits. By
morphologic criteria this epithelium was comparable to a pure principal
cell epithelium. We therefore studied its electrical properties. We used
a modified lucite double-chamber perfused with Ringer's solution. We
observed: after 4 to 8 days of standard cultivation, these epithelia (N =
8) had a transepithelial voltage V of —7.75 3.2 mV (sign referring to
polarity of apical surface) and a transepithelial resistance R, of 2.13
0.41 kflcm2 (room temperature). Supplementation (N 18) of culture
media with 10-6 M aldosterone significantly increased V to —32.3
3.5 mV (P < 0.05), whereas R1 remained unchanged at 2.9 0.3
kflcm2 (P = NS) (room temperature). Temperature elevation to 37°C
further enhanced V1 of aldosterone pretreated epithelia to —59.4 4.4
my (P < 0.05; N = 10), while reducing to 0.83 0.2 kflcm2 (P <
0.05). Further, amiloride 106 M added to the apical perfusion medium
reduced the latter V1 from —59.4 4.4 to —6.7 2 mV (P < 0.05),
while it increased R,, from 0.83 0.2 kIlcm2 to 1.8 0.2 k[cm2 (P <
0.05). However 5 x l0 M BaCI,, an inhibitor of potassium conduc-
tivity, was effective only when applied to the basolateral cell membrane
but not at the apical cell membrane. These observations are suggestive
of active sodium absorption, stimulated by aldosterone in these pure
principal cell epithelia. The high degree of differentiation suggests that
this experimental model is suitable for further studies of principal cell
function.
Renal transport and metabolism of dipeptides. Silbernagl 5,
Ganapathy V, Leibach FH, Volker K. Department of Physiology,
University, D-87 Wurzburg, Federal Republic of Germany, and the
Department of Cell Molecular Biology, Medical College of Georgia,
Augusta, Georgia, USA. Many dipeptides are split in the tubular lumen
and reabsorbed in form of its free constituent amino acids. Other
dipeptides, that is, glycyl-sarcosine (Gly-Sar) and the normal plasma
constituent carnosine (/3-alanyl-L-histidine), are taken up intactly into
brush—border membrane vesicles in vitro. We have measured a frac-
tional reabsorption of carnosine > 99%, and investigated in which
nephron segment these peptides are reabsorbed, and whether they are
metabolized in the lumen, in the cell of the tubule, or at extrarenal sites.
Single tubules (PCT and "loops") of male rats (300g; wt of two kidneys
2.1 g) were microperfused in vivo et situ with solutions containing
'4C-inulin and 3H-Gly-Sar. Carnosine (2.7 mole/min/kg BW) and inulin
were infused i.v. and measured chemically in the femoral artery, the
renal vein, in late proximal (LPT) and early distal (EDT) tubules, and in
the final urine. Results: I) urinary recovery of 3H-Gly-Sar (compared to
'4C-inulin) was 33 2% (sEM), 33 1.4, or 82 2.2% if microinjected
into early proximal tubules, LPT or EDT, respectively. 2) Free flow
TF/P carnosine was 1.08 0.14 in LPT and <0.1 in EDT. 3) Fractional
Gly-Sar reabsorption was 50% per 3 mm in the proximal convolution
and 60 2.4% in the 'loop" during microperfusion (20 nliter/min).
This reabsorption was saturable and inhibited by carnosine (P <0.001),
but neither by L-phenylalanine, N-methyl-L-alanine, L-histidine or
f3-alanine nor by the peptidase inhibitors Bestatin and o-phenanthroline.
4) The renal extraction of carnosine was 0.37 0.06 and not signifi-
cantly different from the filtration fraction (0.31 0.02). 5) The
absolute renal extraction (E) or formation (F) (nmole/min/g kidney) was
302 65 (E) for carnosine, 88 77(F) for histidine and around zero for
/3-alanine. Conclusion: Carnosine and Gly-Sar cross the luminal mem-
brane by a carrier localized in the PCT and especially in the "loop"
(probably pars recta), and are subsequently hydrolized within the
tubule cell. Of the constituent amino acid, a very variable part of His
(mean: 30%) appear in the renal vein whereas /3-alanine is completely
metabolized in the kidney. There is no indication for peritubular
carnosine uptake. At the above carnosine load, the extrarenal carnosine
metabolism is of minor importance (2 1%).
Glycerophosphorylcholine: Concentrations and role in the kidney.
Wirthensohn G, Beck F, Guder WG. Inst. KIm. Chemie, Stadt.
Krankenhaus Bogenhausen, Munchen, and Physiologisches Institut,
Universitdt, Munchen, Germany. Nearly 30 years ago Ullrich and
Schimassek et al reported a substance which was highly concentrated in
the renal medulla. This substance was found to be glycerophospho-
rylcholine (GPC), thought to be an intermediate in the catabolism of
phosphatidylcholine by phospholipase A1 and A2. Although GPC was
proposed to play an important role in cellular osmoregulation, this
provocative suggestion was not followed up. Recent studies suggest
that unknown organic osmolytes may indeed play an important role in
osmoregulation of renal papillary cells. Additionally, interest in GPC
has been recently renewed following its rediscovery by 31P NMR
studies in the kidney. These considerations led to the hypothesis that
GPC may be such an osmolyte, and for this reason we developed an
assay based on enzymatic determination of choline with cholinekinase
after acid hydrolysis of GPC with perchloric acid. GPC concentrations
in heart and testis were found to be 0.16 and 0.92 mole/g fresh wt,
respectively. GPC concentrations in rat renal cortex was 0.56 smole/g
fresh wt and was about tenfold greater in the medulla and about a
hundred fold greater in the papilla. Within the papilla, a concentration
gradient of GPC was found with the concentrations increasing threefold
from base to tip. Studies on the rat renal papilla under different diuretic
conditions showed a positive correlation between GPC concentration
and urine osmolality, a finding consistent with the involvement of this
substance in papillary function. Elucidation of the mechanisms regulat-
ing GPC synthesis and degradation will certainly further clarify the
functional significance of this substance in the renal papilla.
Role of angiotensin II (A H) for water intake. Mann J, Eisele 5, Unger
PH, Ganten D, Ritz E. Departments of Medicine and Pharmacology,
Transepithelial net
chloride flux
Group pmole cm2 s1
1,N=5 110±33
II,N=5 129±19
ll1,N = 7 218 29
IV,N=4 317±50
Transepithelial net
chloride flux
Group pmole cm2 s' %
IA, N = 7 *223 40 103
hA, N = 7 *230 22 78
IIIA,N=7 264±40 21
IVA,N=4 404±44 27
* P = 0.05, mean SEM.
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University of Heidelberg, West Germany. There is increasing evidence
that the renin system plays a substantial role in the physiology of water
intake, that is, thirst. We investigated the role of A II in two models of
experimental thirst: (I) after ligation of the inferior vena cava; (2) after
subcutaneous injection of polyethylenglycol (PEG). Following ligation
of the vena cava inferior, we observed a time—dependent significant
increase of plasma A II concentration (two to fourfold as compared to
sham—operated controls). In parallel, water intake increased. Water
intake could be inhibited by i.v. infusion of the A H antagonist saralasin
(P < 0.05) as compared to rats infused with NaCI (N = 8). Also, the
angiotensin I converting enzyme inhibitor captopril (100 mg/kg) signif-
icantly reduced water intake. (2) After subcutaneous injection of PEG,
we observed a time dependent decrease of intravascular volume and an
increase of plasma A II concentration. The latter was highly correlated
with the amount of water intake. Administration of captopril signifi-
cantly reduced water intake. In a subsequent experiment, blood pres-
sure after PEG injection was continuously registered in conscious rats.
Captopril reduced blood pressure in PEG treated animals. In a further
group, the captopril—induced blood pressure decrease was avoided by
infusion of vasopressin, but water intake was still depressed. We
conclude that endogenously produced A II may substantially stimulate
water intake. This physiological effect does not depend on the mainte-
nance of blood pressure by the octapeptide.
Renal transport of inorganic sulfate (SO4) in the rat: effects of
extracellular fluid volume expansion (ECVE) and metabolic changes of
blood pH. Frick A, Durasin I, Neuweg M. Department of Physiology,
University of Munich, Munich, Federal Republic of Germany. The
clinical significance of inorganic sulfate in the body is still unclear. One
of the reasons for this uncertainty may be the relative difficulty of the
measurement of this anion in plasma. Recently we adapted a SO4
method to enable us to measure the concentration of SO4 in plasma in
small samples and to characterize some aspects of the renal transport of
SO4 in vivo. The present studies describe the effects of volume
expansion and metabolic changes of blood pH. Adult female Sprague—
Dawley rats (250 g b.w.) kept on a standard diet (Altromin) with tap
water ad libitum were anesthetized with Inactin, prepared for clearance
experiments and divided into two groups. 1. Series: Effect of ECVE:
During saline infusion (130 mmole/liter NaCl) at the rate of 0.15
mliter/min (control), the fractional reabsorption of Na was 96.5 2.1
and of SO4 was 90.1 5.6% (mean values SD). At the infusion rate
of 0.375 mliter/min (experimental), these values fell to 84.4 1.3 and
81.6 3.6%, respectively (P < 0.001). 2. Series: Effects of metabolic
changes of blood pH: During constant infusion rate at 0.20 mliter/min of
either 130 mmole/liter NaHCO3 (to induce a metabolic alkalosis; alk.) or
a mixture of 130 mmole/liter NaCI + 130 mmole/liter NH4CI (to induce
a metabolic acidosis; ac.) or 130 mmole/liter NaCI (control) the pH
blood values were 7.49 0.02, 7.29 0.02 and 7.38 0.02,
respectively. The fractional excretion of SO4 was 28.6 5.7 (alk.), 9.5
2.7 (ac.) and 20.7 3.0 (control); the P values (experimental,
control) were < 0.025 and < 0.001, respectively. Conclusions: I.)
Expansion of the extracellular fluid volume inhibits the reabsorption of
SO4 probably in an unspecific manner. 2.) Extracellular proton concen-
trations may regulate the reabsorption of SO4 and may be involved in
the disturbed homeostasis for sulfate during renal insufficiency.
Transport of nucleosides in brush border vesicles of the rat kidney. Le
Hir M, Dubach UC. Medizinische Universitats—Poliklinik, Kantonsspi-
tal, CH-4054 Basel, Switzerland. Renal complications have been re-
ported during therapeutic use of nucleosides (Nu). Little is known
about the transport of Nu in the kidney. We studied the transport of
four purine Nu and of three pyrimidine Nu in brush border vesicles. The
uptake of labelled Nu by the vesicles was measured with a filtration
technique. In the presence of an Nat-gradient across the membrane
(out > in) the time—course of uptake showed an overshoot, the
amplitude of which was dependent upon the anion (SCN  CL '
SO4
- > gluconate). An overshoot was also observed in the presence
of a K +
-gradient provided that Na was present at equilibrium across
the membrane. These findings suggest that Nu are cotransported with
Nat The Km's for 7 Nu range from 1.1 to 8.6 prnole. Iiter. A
countertransport occurred only when the Nu present inside of the
vesicles was of the same class (purine vs. pyrimidine) as the Nu in the
medium. 250 tmole. liter' N-ethylmaleimide provoked about 80%
inhibition of the transport of purine Nu but less than 10% inhibition of
the transport of pyrimidine Nu. These results point at the existence of
two separate carriers, one for purines, the other one for pyrimidines. In
summary, the transport of Nu in the renal brush border shows some
peculiarities when compared to the transport of Nu in other cell types:
1. The Km'S are much lower; 2. there is a cotransport with Na* instead
of a facilitated diffusion; 3. purines and pyrimidines are transported by
separate carriers. The two first properties might explain the sensitivity
of the kidney to some cytotoxic Nu.
The relationship between tubuloglomerular feedback (TGF) and the
increase in glomerular filtration rate (GFR) during acute isooncotic
extracellular volume expansion (VE) in rats. Davis JM, Takabatake T,
Häberle DA. Physiological Inst., Pettenkoferstr. 12, D-8000 Munich 2,
and Dept. of Internal Medicine, School of Medicine, Kanazawa Uni-
versity, Kanazawa 920, Japan. Inhibition or resetting of TGF is held to
be a major factor in the increase of GFR normally seen in yE. The
resetting mechanism is not clear and seems to depend on the model of
VE employed. Thus, in VE due to acute saline infusion, the fall in
plasma oncotic pressure has been implicated. On the other hand, in
chronic VE due to DOCA administration, the characteristics of the JGA
seem to be altered, whereas in chronic VE due to dietary salt loading,
humoral factors in the tubular fluid are responsible for TGF inhibition.
The aim of this study was to examine TGF resetting under acute
conditions comparable to chronic salt loading, that is, isooncotic
expansion of extracellular volume by 30%. This was achieved in male
Wistar rats by i.v. infusion over 10 mm of a volume (4% of BW) of fresh
rat plasma from a litter mate, diluted with Krebs—Henseleit solution (1:3
vol/vol). TGF activity was then tested by measuring nephron GFR
(NGFR) in response to loop of Henle perfusion at 0, 15 or 40 nliter/min
with either Ringer's solution or harvested homologous tubular fluid
(TF). Compared with non-expanded controls, VE significantly in-
creased NGFR in the absence of a TGF signal (that is, at zero loop
perfusion) from 36.7 9.2 to 59.6 9.7 nliter/min/gBW (mean SD).
Ringer's 1oop perfusion at IS nliter/min reduced NGFR in controls to
69% and in VE to 90% of its value at zero loop flow, corresponding to
diminutions of 10.9 4.4 and 6.2 6.4 nliter/min/gBW respectively.
During 1oop perfusion at 40 nliter/min, NGFR in controls was reduced
to 59% and in VE to 62%, corresponding to diminutions of 14.7 6.7
and 23.0 7.1 nliter/min/gBW respectively, the latter being signifi-
cantly greater (P < 0.05) than the former. Loop perfusion with TF at 15
and 40 nliter/min in VE reduced NGFR to 78 and 62% respectively,
corresponding to reductions of 10.5 7.2 and 22.5 6.7
nliter/min/gBW respectively. These values are not significantly different
from those achieved with Ringer's loop perfusion. From these results it
is concluded that, in contrast to YE due to chronic dietary salt loading,
acute isooncotic VE actually enhances TGF activity, particularly at
higher loop flow rates. GFR increases because of simultaneous and
substantial increases in the glomerular driving forces, as can be clearly
seen in the absence of the TGF signal.
Acute hormonal and hemodynamic effects of atrial natriuretic factor
(ANF) in man. Witzgall H, Gerzer R, Hamet P. Medizinische Klinik
Innenstadt der Unjyersität München and Clinical Research Institute,
Montreal, Canada. ANF is a recently discovered peptide hormone that
is a potent vasodilating as well as natriuretic and diuretic agent in
animals. Furthermore, ANF has been shown to stimulate cyclic GMP
formation. A bolus injection of 50 sg ANF(—hANaP) was given iv. to
ten healthy male subjects (25 to 37 years) under controlled fluid and
electrolyte balance after two hrs in supine position. For analyses, blood
and urine were taken before and after the injection, respectively. Blood
pressure was determined automatically every two minutes (Binamap
Monitor). Plasma ANF, cGMP, and cAMP levels were determined by
radioimmunoassay. Diastolic blood pressure fell by a mean of 7 mm Hg
two mm after ANF. ANF and cGMP plasma levels, however, increased
in parallel threefold over basal levels two mm after injection. Thirty mm
later, both levels were normalized again. Plasma cAMP levels remained
unchanged after ANF. Urine volume increased by about 50% and
sodium excretion rate by about 100% within 30 mm after ANF, whereas
chloride excretion remained unchanged and potassium excretion was
slightly decreased. No side effects were observed following ANF
administration. The results indicate a rapid natriuretic and vasodilating
effect of a small dose of ANF in man. The parallel increase of ANF and
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cGMP plasma levels suggest that cGMP and not cAMP levels are
regulated by ANF in man.
Relationship between the atrial natriuretic factor and the renal kal-
Iikrein—kinin system in normotensive and hypertensive rats. Bönner G,
Hirzel B, Bbchsler U, Kapp Ch, Ganten D. Department of internal
Medicine II, University of Cologne and Department of Pharmacology.
University of Heidelberg, Germany. Atrial natriuretic factor (ANF) or
atriopeptin (AP) develops a marked natriuretic and diuretic effect in
circulation. Additionally ANF reduces blood pressure (BP) by vasodi-
lation. The mechanisms by which ANF develops its actions, however,
are still unknown till today. Probably ANF interacts with the glandular
and specially the renal kallikrein—kinin system, since its effects are
similar to that of the kinins. To investigate the possible interaction of
the two hormone systems rat AP III (3.5 pg/kg of body wt) was injected
intravenously as a bolus into four normotensive Wistar—Kyoto rats
(WKy-A) and into four spontaneously hypertensive rats (SHRsp-A).
Control rats (P' = 4) were injected with the same volume of isotonic
saline (WKy-C; SHRsp-C). Measurement was performed for: systolic
blood pressure (BPs), activity of kininase 11 in plasma (KIl), plasma
concentration of kininogen (PKG) and sodium (PNa), urinary excretion
of kallikrein (UKaIV), kinins (UKiV), sodium (UNaV), potassium
(UKV) and water (UV). Injection of AP produced a marked decrease in
BPs (WKy-C: 133 33 v.s. WKy-A: 106 7 mm Hg). UNaV
increased highly (WKy-C: 0.38 0.1 vs. WKy-A: 5.57 1.5
jtmole/min) as well as UV (WKy-C: 5.6 0.7 v.s. WKy-A: 31.6 4.7
diter/min). Simultaneously UKV increased (WKy-C: 0.9 0.1 vs.
WKy-A: 2.1 0.3 mole/min). Renal kallikrein—kinin system was
activated since UKaIV (WKy-C: 2.0 0.2 v.s. WKy-A: 4.0 1.6
mU/mm) and UKiV (WKy-C: 6.7 2.1 v.s. WKy-A: 8.8 1.6 pg/mm)
increased. No change was observed in activities or concentrations of
compounds measured in plasma (that is, PKG, KIt, PNa). In the SHRsp
(-C and -A) identical changes in all parameters were found. Even in the
SHRsp reduced basal UKaIV showed a to the WKy comparable
increase after AP injection (SHRsp-C: 0.77 0.2 v.s. SHRsp-A: 1.87
0.37 mU/mm). The results show that ANF develops a marked blood
pressure lowering activity and a very strong diuretic and natriuretic
effect. These effects are accompanied by a clear increase in the activity
of the renal kallikrein—kinin system (KKS) with enhanced kallikrein and
kinin excretion. The stimulation of renal KKS seems to be independent
of the actual blood pressure, since no clear difference between WKy
and SHRsp was seen.
Influence of atriopeptin III on rabbit aortic smooth muscle: relaxation
and increase of cGMP. Linz W, Albus U, Wiemer G, SchOlkens BA,
Hoechst AG. D-6230 Frankfurt M 80, West Germany. Atriopeptin 111
(AP III), a synthetic peptide with 24 amino acids representing a
fragment of the atrial natriuretic factor, was investigated in isolated
rabbit aortic rings with intact or functionally destroyed endothelium. In
addition levels of cAMP and cGMP in vascular tissue were determined.
Aortic segments were precontracted with norepinephrine (NE 10 M),
angiotensin II (ANG 1110 M) or potassium chloride (KCI 20 mM).
After addition of AP III (10-10 to 10 M) a concentration dependent
relaxation was seen which was independent of intact endothelium, with
EC50 values of 2.2 x l0 si, 2.0 x l0 M and 3.1 x 10 M,
respectively. In contrast, acetylcholine (ACh) induced an endothelium
dependent relaxation of aortic segments, precontracted with NE and
ANG It. After KCI-contraction, no vasorelaxant effect was seen. In
aortic segments with functionally destroyed endothelium basal cGMP
levels, measured by RIA, were lower compared with intact vascular
tissue. The relaxation induced by AP III and ACh was associated with
marked significant (P < 0.01) increases of cGMP in intact vascular
tissue, whereas aortic preparations with functionally destroyed endo-
thelium had only marginally increased cGMP levels, in both prepara-
tions the cAMP levels were unchanged. We suggest that AP Ill elicits
a direct endothelium—independent vascular relaxation associated with
increased cGMP levels in tissue with intact endothelium. Extrusion of
intracellular Ca * by activation of a cGMP-dependent proteinkinase
may be part of the vasorelaxant profile of AP III.
Atrial natriuretic peptide in plasma of children with end—stage renal
disease and volume expansion. Rascher W, Tulassay T, Lang RE.
Division of Pediatric Nephro!ogy, University Children's Hospital and
German institute for High Blood Pressure Research, Heidelberg, West
Germany. The role of human atrial natriuretic peptide (ANP) in the
regulation of extracellular fluid volume was studied by means of a
sensitive and specific radioimmunoassay. In children with end—stage
renal disease plasma concentrations of ANP, arginine—vasopressin
(AVP), aldosterone (PA) and plasma renin activity (PRA) were mea-
sured before and after a hemodialysis session. Children with advanced
chronic renal failure (serum creatinine 5.8 2.7 mg/dliter; x SD) had
ANP levels (27.8 18.3 fmole/mliter) similar to age—matched healthy
children (19.2 8.9 fmole/mliter), whereas ANP was markedly ele-
vated in children with end—stage renal disease before hemodialysis
(HD) (87.1 39.4 fmole/mliter, P < 0.001). During HD, ANP fell
significantly and PRA rose slightly (Table).
Plasma ANP correlated positively with volume status (body wt gain
during the interval between two hemodialysis sessions; r = 0.71, P <
before HD after HD
14 14 P value
Body wt, kg 39.4 7.8 37.2 7.6 <0.001
hematocrit, % 19.7 3.9 24.2 5.2 <0.001
AVP, pg/mliier 12.9 4.6 14.2 8.2 NS
PRA, ngA i/mi/hr 2.5 2.9 3.7 4.2 <0.05
PA, ng/dliter 39.3 37.7 28.5 34.8 NS
ANP,fmole/mliter 87.1 39.4 42.8 26.2 <0.001
0.001). An expanded extracellular fluid volume thus seems to be a major
stimulus for the rise in ANP in children with end—stage renal disease.
This finding suggests that ANP may be important in volume
homeostasis.
Protection from acute, ischemic renal failure: the reduction of vascular
congestion as an underlying mechanism. Mason J, Weisch J, Torhorst J.
Physiology institute, Munich and Pathology Institute, Base!, Switzer-
land. Following a period of temporary ischemia, the rat kidney displays
a prominent hyperemia of the outer medulla, similar to that seen in the
shock kidney in man. it consists of a congestion of the vasculature with
densely—packed erythrocytes that can be assessed both qualitatively by
grading and quantitatively by morphometry. The good correlation
between the degree of vascular congestion in the medulla and the extent
of the restriction in renal function suggested a possible causal relation-
ship between the two. To test this hypothesis, the arterial hematocrit
was reduced by isovolemic transfusion to 30% before ischemia and
raised to 42% after ischemia in an attempt to reduce the degree of
congestion. This treatment eliminated nearly all of the customary
medullary hyperemia and raised glomerular filtration rate from just 15%
in control animals to more than 50% of normal 3 hr after ischemia. To
investigate whether vascular congestion might result from cell swelling
and an uptake of plasma water into the cells, a 450 mM/liter mannitol
solution was infused into the kidney for just 90 sec before ischemia to
increase the osmolality of the extracellular space by at least 15
mOsM/liter. This treatment also eliminated most of the medullary
hyperemia and raised glomerular filtration rate to more than 50% of
normal 3 hr after ischemia. Finally, to determine the influence of
metabolic substrates, glucose was administered before ischemia, and
fructose diphosphate or adenosine was given intrarenally just before
and for some while after ischemia. All these treatments decreased the
degree of medullary hyperemia and increased glomerular filtration rate
to approximately 50% of normal 3 hr after ischemia.
it is concluded that renal failure after ischemia is largely caused by a
vascular congestion, which is particularly prominent in but not exclu-
sive to the outer medulla. This congestion most probably results from
GFR
ml/min//00 g
(Mean SEM)
untreat.
61 257
GFR mannitol gluc. fruct. aden.
269 255 179 203
N
normal
399
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mnI/min/lOOg
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Abstracts 1255
cell swelling during ischemia, with an associated depletion of plasma
water. Procedures that hinder this mechanism or speed its reversal,
thereby allowing a more rapid oxygen and substrate delivery to the
ischemic tissue, improve renal function greatly.
Pharmacology, therapy
Torasemide, a diuretic blocking both the Na2ClK carrier and
C1-channels. Wittner M, Schlatter E, Delarge J, Greger R.
Max—Planck—Institut für Biophysik, Frankfurt, Federal Republic of
Germany, and Institut de Pharmacie Liege, Liege, Belgium.
Torasemide (TOR) was tested in isolated Torasemideperfused segments of the thick ascending
limb of the loop of Henle (TAL) of mouse CH3
and rabbit, as well as in isolated perfused
rectal gland tubule segments (RGT) of the NH
dogfish (squalus acanthias). In the TAL
segments the equivalent short circuit cur- N S02N
rent (Isc), reflecting the active reabsorption I
of NaCI, as well as the voltage across the CONHC3H7
basolateral membrane (VbI) were measured. In RGT segments, in
addition, the effect of TOR on individual C1-channels was tested in
excised membrane patches of the apical membrane using the patch
clamp technique. The table comprises the data obtained in rabbit TAL
segments. 'Sc in the presence of TOR is given in % of control values.
Lumen
(mole/liter)
'Sc + SE (N) 75
io—
9 (4)
10
25 9 (3) 10
l0—
4 (4)
Bath
(mole/liter) l0- l0- l0-
'Sc + SE (N) 3 (3) 78 8 (6) 29 II (5)
TOR added to the lumen perfusate inhibits half maximally (IC0) at 3
l0- mole/liter. From the blood side 3 i0— mole/liter are required.
Both effects are reversible. As predicted for interaction with the
Na2ClK carrier, luminal TOR hyperpolarizes V61 from —61 4 to
—77 4 mV (N = 5). Also, bath addition of TOR, like predicted for a
Cl -channel blocker, hyperpolarizes VhI from —65 7 to —75 7 mV(N = 3). In ROT segments TOR also reduces the transepithelial voltage
when added to either epithelial side. In isolated membrane patches (N
= 6) TOR (l0- mole/liter) inhibits Cl—-channel activity reversibly. We
conclude that TOR not only interferes with the Na 2Cl - K* carrier but
that at higher concentrations, TOR is also able to block the Cl-
channels, present in TAL and in RGT segments.
Pharmacokinetics of the loop diuretic muzolimine in hypertensive
patients with mild renal failure. Mann J, Ritter W, Heckmann M, Ritz E.
Medizinische Klinik, University of Heidelberg, and Bayer-AG, Pharma-
Forschungszentrum, Leverkusen, West Germany. We investigated
pharmacokinetics and clinical effects of the loop diuretic muzolimine in
nine hypertensive patients with mild renal failure (serum creatinine 1.5
to 3.5 mg/dliter; baseline blood pressure above 150/90 mm Hg; age: 29
to 59 yr). Pharmacokinetics were determined twice: after the first dose
and following eight weeks of chronic treatment with muzolimine. All
diuretic treatment was stopped for at least two weeks prior to the study.
Muzolimine was then given as a single oral dose of 20 mg, and blood
taken at timed intervals for the measurement of plasma drug concen-
tration by HPLC. Patients continued to take 20 mg muzolimine o.d.
After another four weeks, trough levels were determined. After eight
weeks, pharmacokinetics were determined as on the first day of the
investigation. We found that the maximal plasma concentration of
muzolimine on chronic treatment was higher in all patients as compared
to the drug concentration on the first day. Plasma half life of muzolimine
was unchanged, but the area under the curve (AUC) was consistently
increased in our patients. The clinical findings included a significant
reduction of body wt (mean 1.8 kg/patient), and a reduction of systolic
blood pressure by II and of diastolic blood pressure by 5 mm Hg.
Interestingly, endogenous creatinine clearance increased in all patients
(from 33 10 to 42 5 mliter/min). There were no significant changes
of routine laboratory parameters, including serum electrolytes. Our
data indicate that muzolimine plasma concentrations in patients with
mild renal insufficiency are higher on chronic than on acute dosing.
Reversible modification of the Na-channel in isolated frog skin
epithelium by 4-(3-dimethylamino-2-hydroxy-propoxy)triamterene and
amiloride. Kipnowski J, Passon J, Detjen G, Düsing R, Kramer Hf.
Medizinische Poliklinik, University of Bonn, Bonn, Federal Republic of
Germany. In the isolated frog skin epithelium, the transport of Na* is
viewed as two consecutive processes: Na*entry into the epithelium
across the outer (apical) barrier via specialized Na-channels along its
electrochemical gradient, followed by active extrusion across the inner
(basolateral) barrier via the sodium/potassium—pump. It has been
shown by several laboratories that the kinetics of the passive Na-entry
process display saturation characteristics. The diuretic drug amiloride
inhibits specifically, with high affinity, and reversibly active Na-
transport in amphibian epithelia by binding to or close to the Na*.
channel. The present study was performed to characterize the
steady—state transport kinetics of the interaction between 4-(3-
dimethylamino-2-hydroxypropoxy)triamterene (RPH 2823) and
amiloride (A) with external Na* in the isolated frog skin epithelium of
R. esculenta. Transepithelial Na*.transport, measured as the
short—circuit current (SCC), and normalized by the values obtained
from untreated control skin halves, was reversibly and significantly
inhibited by apical RPH and A: RPH (N = 6 to 11): l06 M: 0.89
0.04, P < 0.05; l0 M: 0.74 0.03, P < 0.001; l0- M: 0.40 0.02,
P<0.00l; lO3M:0.ll 0.05,P<0.00l;A(N = 6to9): 108M:0.89
0.02, P <0.001; l0- M: 0.65 0.03, P <0.001; 10-6 M: 0.42
0.05, P < 0.001; iO M: 0.19 0.04, P < 0.001; l0 M: 0.04 0.03,
P < 0.001. This dose—dependent decrease in normalized SCC during
apical RPH and A was paralleled by a significant increase in transepi-
thelial electrical resistance (R). The correlation between SCC and R
was analyzed by linear regression: R = 2.05 — 1.06 SCC (RPH) and R
= 1.83 — 0.84 SCC (A). The correlation coefficient r was —0.99 for
both curves. The Hill—inhibitory plot of the RPH— and A—induced
decrease in SCC at an external Nat-concentration of 110 m revealed
a slope of the regression line of 0.59 and 0.56, respectively. The
apparent dissociation constant for Na* (K1) in the absence of RPI-I and
A was 4.71 mt. l0 M RPH and 5 x lO M A resulted in a significant
increase in K1 by a factor of 3.0 and 2.8, respectively. However, since
SCCaX was also significantly reduced, we conclude that the interaction
of RPH and A with Na* at the sodium entry site is of a mixed
competitive—noncompetitive type. Stimulation of Na-transport by
ADH (5OmU/mliter, final serosal concentration) of RPH- and A-pre-
treated skin halves resulted in a significant lesser absolute increase in
SCC when compared with the values obtained from the control skin
halves. However, the fractional increase in SCC after ADH of RPH-
and A-pretreated skin halves was comparable to that obtained from the
control tissues.
EWect of lithium on kidney function, serumproteinuria and excretion of
tubular membrane proteins in psychiatric patients. Scherberich JE,
Demisch K, Wehrheim C, Rosskopf H, Bauer J, Schoeppe W. Abt.
Nephrologie u. Abi. k/in. Psychiatric, Univ. Frankfurt am Main,
Federal Republic of Germany. In order to study possible drug mediated
involvement of the kidney, the excretion of serumproteins and tubular
proteins in urine was studied in 32 manic-depressive patients (14 F 18
M, mean age 42.6 years) under lithium (Li) therapy. Aliquots of the
patients' urine (24 hrs collection period) were assayed for brush border
associated ala-(leu,gly-)aminopeptidase (AAP,EC 3.4.11-) and the ma-
jor tubular surface glycoprotein ("SOP-antigen") of mole wt 240 kd.
SOP-antigen, containing mannose and N-acetylglucosamine, was mea-
sured by immunological techniques applying specific antisera from the
rabbit. Patients under Li treatment excreted significantly higher
amounts of brush border related proteins compared with a control
group of healthy persons (N = 16, 2p:3 x l0, Mann—Whitney test),
and a second control group of psychiatric patients treated with various
drugs except Li. However, mean values of the second control group
were higher as in healthy persons. Renal tissue—proteinuria of AAP and
SOP-antigen in Li treated patients correlated positively to the Li
concentration in the serum (R5 = 0.58, 2p = l0), which was in the
range of 0.49 to 1.0 mval/liter. Significant positive correlations were
also found between the excretion of AAP and SOP-antigen, enzymuna
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and serum osmolality (R5 = 0.45, 2p:O.Ol), enzymuria and urine
volume (R5 = 0.69, 2p = 9 l0), Li-concentration in serum
(mval/liter) and serum osmolality (mOsmole/liter, 2p = 10-6), duration
of Li-therapy and serum osmolality, serum osmolality and urine vol-
ume, as well as between kidney tissue proteinuria (AAP, SGP concen-
tration in urine) and duration of Li-therapy, ranging from 6 to 123
months. Excretion of tubular membrane proteins was higher in the
subgroup of patients with albuniinuria (Albustix 30 mg/dliter, N =
19), compared to the group of patients without significant albuminuria
(Albustix negative, N = 13). A significant negative correlation was
found between serum Li-concentration and creatinine clearance (R =
—0.61, 2p 6.5 l0), tissue proteinuria and creatinine clearance (R
= —0.95, 2p: 10- 7), duration of Li-therapy and creatinine clearance (R
= —0.81), serum osmol. and creatinine clearance. Thin layer SDS-
PAGE disclosed a tubular pattern of proteinuria in 18 out of 32, a
glomerulotubular profile in 5 of 32 patients, while 9 of 32 showed a
physiological type of proteinuria. We conclude that Li may effect both
the glomerular filter as well as the structural integrity of the proximal
tubule. Alteration of renal function (GFR), modulation of glomerular
permselectivity and disturbance in tubular protein reabsorption due to
Li-therapy revealed a dose relation and a time (duration of therapy)
dependency.
Potency of vitamin D3 metabolites to inhibit keratinocyte proliferation
parallels their binding affinities to the calcitriol receptor. Merke J, Weher
A, Huge! U, Fursienberger G, Ritz E. Department of internal Medicine
and German Cancer Research Center, Heidelberg, Federal Republic of
Germany. Recently, receptors for l,25(OH)2 vitamin D3 (calcitriol)
have been recognized in non-classical target organs of vitamin D3, that
is, organs which are not involved in homeostasis of calcium metabo-
lism. We have recently characterized calcitriol receptors in the stratum
basale of the skin. Furthermore, in chronically uremic animals a
reduction of binding sites was observed. It is unclear to what extent the
action of vitamin D metabolites on keratinocytes is mediated via
nuclear receptors by interaction with the genome or via direct
liponomic interaction with the cell membrane. To further clarify the
mechanism involved, we compared inhibitory effect on proliferation of
basal keratinocytes and binding affinity to the nuclear receptor for
different vitamin D metabolites. Methods: From the dorsal skin of
neonatal/adult non-ricketic Albino mice (NMRI) epidermis was shock
frozen (— 80°C) and in parallel cells obtained for primary cultures
(collagen digestion after Yuspa and separation of basal cells by Percoll
density gradient). Calcitriol receptors in nuclear fraction were charac-
terized by sucrose density gradient, Scatchard plot, DNA affinity
chromatography. Dose— and time—dependence of action of vitamin D
metabolites on [3H1 thymidine incorporation (DNA synthesis) in pri-
mary basal cell cultures. Results: Specific nuclear calcitriol receptors
(3.5 Svedberg, K0 1.3 x 10-10 M; N = 103 fmole/mg protein;
DNA cellulose elution at 0.27 M KCI) were demonstrated; competition
studies showed highest receptor binding affinity for calcitriol, that is,
half maximal [3H] calcitriol displacement (ED0) by I x molar calcitriol
excess; 150 x 25(01-1)1)3; 300 x la(OH)D, 450 x 24, 25(OH)2D.
Proliferation inhibition by D-metabolites, relative to [3H] dTd incorpo-
ration over 10- to 10-6 M concentration and 896h incubation, was
minus 68% for calcitriol, minus 40% for la(OH)D, minus 7% for 24R,
25(OH)2D3 and 0% for 25(OH)D3. Conclusion: Parallelity of binding
affinity and inhibitory action on cell proliferation in mouse basal
keratinocytes suggests genomic action of vitamin D metabolites in skin.
Cephalosporin (Cefodizim) transport in the rat proximal renal tubule.
Ullrich KJ, Ru,nrich G, Schrinner F. Max—Planck—institut fur
Biophysik, Frankfurt/Main und hoechst AG, Frankfurt/Main, Federal
Republic of Germany. Kasher et al have shown that the COOH -
containing cephalosporin and the zwitterionic pyridyl compound
Cephaloridine inhibit luminal and contraluminal PAH transport, and
that the latter compound inhibits in addition, luminal organic cation
transport. Furthermore, lnui and collaborators have shown that
aminocephalosporin can cross the brush border membrane by two
different carrier—mediated carrier systems, those for organic cations
and those for dipeptide. We tested now the transtubular active transport
of Cefodizim (HR 221) which contains a COOH-group on the 5-thia-
1-azabicyclo-ring and in addition a 2-amino-thiazol- as well as a
2-carboxymethyl-thiazol-ring. For this, the transtubular concentration
difference of Cefodizim at zero transtubular net flux was measured.
Starting concentration was I mmole/liter Cefodizim in both luminal and
capillary perfusate. After 45 sec contact time, the luminal concentration
was increased by 0.18 0.03 mmole/liter, indicating active secretion of
this substance. If 10 mmole/liter paraaminohippurate was in the perfus-
ates, the transtubular concentration difference of Cefodizim vanished.
But if 10 mmole/liter of glycyiglycin or prolylglycin—which is more
resistant against hydrolysis—was in the perfusates, the luminal concen-
tration increased by 60 and 80% respectively. 10 mmole/liter 2-
oxoglutarate, sulfate or tetraethylammonium was without effect on the
zero net flux transtubular concentration difference of Cefodizim. The
same holds if Na* was omitted from the perfusates. The data indicate
that Cefodizim is actively secreted in a Nat-independent manner,
apparently through the PAH transport system at the contraluminal and
the dipeptide transport system at the luminal cell side.
Cefodizim (HR 221)
H2N\OLcH212_cooH
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Cyclosporin A inhibits the Trypanosomiasis—induced nephrotic syn.
drome in the rat. Ehrich JHH, Oemar B, Kerb W, Fleuren GJ, Bru,jn
JA, Wonigeit K. Medical School Hannover, Federal Republic of
Germany, and University of Leiden, Leiden, The Netherlands.
Trypanosomiasis (T) in BD IX rats is associated with an immune
complex glomerulonephritis and a nephrotic syndrome (NS). This study
was designed to test the hypothesis that the Trypanosomiasis-NS can
be treated with cyclosporin A (CSA). In the first experiment, fifteen
male BD IX rats were infected intraperitoneally with 250 Trypanosoma
brucei brucei and received 14 mgld/kg body wt CSA i.m. between day
25 and 60, post infection. Mean CSA trough blood level was 3161
ng/mliter 186 si on 47 d.p.i. Mean proteinuria (PU) was elevated on
day 25 and decreased during CSA therapy from 13.9 mg/day 3 SD to
6.3 mg/day 0.4 SD on day 57; in contrast at this timepoint mean PU
in untreated infected rats had reached 173 mg/day 26 SD. Mean
albuminuria in CSA—treated Trypanosomiasis rats was significantly
lower than in untreated animals (0.4 mg/day 0.1 SD vs. 67 mg/day
17 SD). Parasiternia persisted in both groups; 60 d.p.i. mean parasitemia
was l48,000/zliter in the CSA treated group and 325,000/sliter in
untreated rats. In both groups, immunofluorescence microscopy
showed granular deposits of IgG and 1gM in the glomeruli 25 and 60
days after infection, however, the intensity of deposited immunoglob-
ulins on day 60 was less in the CSA-treated rats. In a second experi-
ment, 8 BD IX rats infected with T for 59 day and presenting a high PU
were treated with CSA for 27 days. Mean albuminuria decreased from
93 23 SD to 44 mg/day IS SD on day 86. It can be concluded that
firstly a five weeks course of cyclosporin A inhibits the development of
a trypanosomiasis induced nephrotic syndrome (TNS) and secondly
that CSA reduces proteinuria after TNS is established.
Clinical nephrology, dialysis
Glomerulonephritis in ANF negative SLE with low complement.
Andrassy K, Koderisch J, Darai G, Tilgen W, Ritz E. Medizini.cehe
Univ. Klinik, Univ. Hautklinik und institut Medizinische Virologie.
Heidelberg, Federal Republic of Germany. In patients with SLE,
decreased levels of CH5O, C3 and factors of the classical C pathway
(Cl, C2, C4) are usually indicative of visceral involvement, particularly
proliferative glomerulonephritis. Against such background of clinical
experience it is of note to point out the existence of markedly
hypocomplementemic SLE patients who have only mild renal involve-
ment but pronounced and well defined cutaneous manifestations, that
is, photosensitive annular and papulosquamatous exanthema with cu-
taneous vasculitis. We observed six cases (out of 20 consecutive, newly
diagnosed SLE patients), all women, who had normal renal function
(Ccr), modest proteinuria (1.5 g/day) and microhematuria. On renal
biopsy, the only finding was mild mesangial proliferation with low
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activity and chronicity index. We found modest leucocytopenia,
thrombocytopenia and anemia, but there were no further indications of
visceral involvement. All patients complained of arthralgia and myalgia.
ANF and binding of dsDNA (Farr test) were negative (but became
positive in the subsequent clinical course in two patients). in contrast,
antibodies against extractable acid nuclear antigens, that is,
SSA(Ro)/SSB (La), were present in high titers. There was no excess of
DR2 or DR3 respectively. IEF and PAGE gave no evidence of congen-
ital complement defects. Epidermal band test was positive. Cutaneous
lesions and arthralgia responded to chloroquine alone in four patients
and low dose prednisone was required in addition in the other two
patients. From a nephrological point of view, identification of this
subgroup appears justified because of its diagnostic (negative ANF and
Farr test despite GN), prognostic (little visceral involvement despite
hypocomplementemia) and therapeutic pecularities (frequent favorable
response to chloroquine alone).
Goodpasture's syndrome as post-mycoplasma—pneumonia infection.
Schaar H, Eberle P, Mahieu Ph, Schepers G, Sieberth HG. Depart-
ment Innere Medizin 11 Technical University Aachen, Federal Republic
of Germany and Department Pediatric and Internal Medicine, Slate,
Liege, Belgium. Goodpasture's syndrome has a comparable disease in
cows, caused by mycoplasma bovirhinis infection. This description
gave us the idea to prove if Goodpasture's syndrome follows a
mycoplasma pneumonia infection. Indeed, our experiments demon-
strate that antibodies against mycoplasma pneumonia also fit the
glomerular basement membrane. This could be shown by indirect
immunofluorescence and the solid phase radioimmunoassay. We inves-
tigated sera from 12 patients suffering from Goodpasture's syndrome,
which had an impressive positive mycoplasma pneumonia complement
binding reaction and showed a growth inhibition for this mycoplasma
species. Antigenic determinants in mycoplasma pneumonia are situated
in an glycosphingolipid with terminal alpha-A-galactosyl—groups, there
are also terminal alpha-A-galactosyl—groups in the human basement
membrane. In sera from Goodpasture's syndrome patients, as in
patients with mycoplasma pneumonia infection, we found a signifi-
cantly high titer in alpha-A-galactosyl antibodies, which we could
identify as IgG antibodies. Analyzing the investigations we conclude
that Goodpasture's syndrome may follow a mycoplasma pneumonia
infection.
Biochemistry of Tamm—Horsfall glycoprotein in diabetes mellitus.
Rambausek M, Heuck CC, Dulawa J, Jann K, Ritz E. Department
Internal Medicine and Pediatrics, Heidelberg and Max—Planck—Institut
für Immunologie, Freiburg, Germany. Tamm—Horsfall glycoprotein
(THP) of diabetic patients has been shown to have abnormal carbohy-
drate composition and reduced colloid stability, particularly in the
presence of x-ray contrast medium and albumin. To further analyze the
causes of such colloid instability, N-acetyl-neuraminic acid content,
isoelectric point (p1) and surface charge density of the THP molecule
were determined. THP was isolated from the 24 hr urine of 15 type I
diabetics with normal renal function and no major proteinuria, and 15
age and sex matched controls using NaCI-precipitation after Tamm and
Horsfall. Purity was checked with SDS PAGE and Ouchterlony tech-
nique. NANA were determined using the thiobarbiturate method after
Warren, charge density and p1 were determined by polyelectrolyte
titration in the pH range 3.0 to 8.0 as described by us previously.
NANA of THP of diabetic patients was significantly reduced (3.62
0.25 g/100 g THP in diabetes vs. 4.96 0.15g/l00 gin controls). in the
entire pH range from pH 3.0 to 8.0, less dissociable charges were
present on diabetic THP as compared with control THP (at pH 5: diab.
THP-0.l x l0 units/g lyophil. THP; Co-THP —0.24 x l0 units/g
THP). isoelectric point of THP of diabetic patients was 3.5 vs. 3.0 for
THP of control patients. It is concluded that THP of diabetic patients
has reduced NANA content, reduced charge density and an isoelectric
point at more alkaline pH. These findings may be relevant for the more
pronounced tendency of THP from diabetic patients to precipitate in the
presence of albumin and x-ray contrast media.
Inhibition of the Na/H-antiport in human renal brush border
vesicles by a sulfated bile acid. Sellinger M, Haag K, Mielke G, Gerok
W, Knauf H. Department of Medicine, University of Freiburg 7800,
Federal Republic of Germany. Patients with obstructive jaundice are at
a high risk for acute renal failure (ANV) after surgery. Direct toxic
membrane effects of direct bilirubin or bile acids as well as systemic
alterations in hemodynamics and coagulation have been discussed as
possible causes. The tubular cells are prone to hypoxemia, as described
in different animal models of obstructive jaundice. This induced us to
investigate the influence of direct bilirubin and bile acids on Na/H-
exchange and ion permeabilities in brush border membrane vesicles
(BBV) from the human kidney. The pH-sensitive dye, acridine orange,
was used to study proton movement fifteen under various conditions.
The enriched human BBV (membrane marker AAP enriched fifteen
fold) exhibited a Nat/H +
-antiport system of high selectivity and
efficacy (70% electroneutral Na/H-exchange) sensitive to amiloride.
Nat- and K-permeabilities were small compared with H-permeabi-
lity. Bilirubin conjugate (300 M) as well as taurine and glycine
conjugates of cholic acid and chenodesoxycholic acid (30 M) had no
significant effect on transport properties in BBV. However, the addition
of sulfated chenodesoxycholic acid (S-CDCA) resulted in a 50% inhi-
bition of the electroneutral Na/H f-exchange. Significant inhibition
was seen at lower concentrations of S-CDCA (5 jM). A bile
acid—induced impairment of vesicle preloading or pH-sensitivity of
acridine orange as well as changes in ion permeabilities were excluded
by additional experiments with different ionophores. Furthermore, the
activity of the membrane marker AAP in BBV was not changed by the
addition of 30 jM S-CDCA. Of the bile acids tested, the sulfated bile
acid S-CDCA was the only one to significantly inhibit the Na/H-
antiporter. Sulfated bile acids occur in the presence of obstructive
jaundice in man and are concentrated in the urine. Inhibition of the
Na/H-antiporter by sulfated bile acids may result in tubular necrosis
due to impaired cellular pH-regulation. This pathomechanism may
explain the postoperative acute renal failure in patients with obstructive
jaundice.
Effect of nifedipine on carbohydrate metabolism of glycerol—induced
acute renal failure in the rat. Haag M, HOrl WH, Riegel W, Heidland A.
University of Freiburg and Wurzburg, Federal Republic of Germany.
Calcium antagonists have a protective effect on ischemic acute renal
failure. An inhibition of insulin secretion and an increase of serum
glucose is reported by various authors. The study was designed to test
both the possible protective effect of nifedipine on the acute
hemoglobinuric renal failure and the effect on carbohydrate metabo-
lism. Female Wistar rats received a diet containing 0.6 g nifedipine per
kg food for 12 days. Controls ingested equal amounts of food without
nifedipine. After this period, acute renal failure was induced by
injecting 2 muter of 50% glycerol i.m. The animals were kept in single
metabolic cages, diuresis and electrolyte excretion was measured. The
rats were killed 2, 4, 6 and 8 days after glycerol injection. We tested in
vitro in isolated hepatocytes the effect of different nifedipine concen-
trations on the gluconeogenesis. Nifedipine lead to a significant increase
of diuresis, sodium, potassium, calcium, chloride and phosphate excre-
tion. Higher urea and serum creatinine levels were measured after
glycerol injection in the group fed with nifedipine. Nifedipine lead to a
significant increase of glucose content in liver (38.4 2.8 vs. 19.9 1.2
g/mgprotein;P = 0.001) and kidney (40.5 1.9 vs. 25.1 l.6g/mg
protein; P = 0.001), further to a significant rise of lactate in liver (44.8
4.9 vs. 26.5 1.8 nmole/mg protein; P = 0.001) and kidney (53.8
3.7 vs. 41.7 2.3 nmole/mg protein; P = 0.01). Glycogen content in
liver, however, was in the group with nifedipine significantly lower
(47.9 4.9vs. 132.6 17.1 g/mgprotein). Usingserine,pyruvateand
dihydroxyaceton as substrates nifedipine had in a concentration of l0-
to 10-8 M no effect on gluconeogenesis in isolated hepatocytes of
acutely uremic rats. A nifedipine concentration of l0- M, however,
lead to a significant production of lactate using pyruvate as substrate.
Conclusions. Nifedipine has no protective effect on glycerol—induced
acute renal failure of rats. Nifedipine has a glycogenolytic effect.
Nifedipine does not stimulate gluconeogenesis in isolated rat
hepatocytes. Following glycerol—induced acute renal failure, nifedipine
leads to a compensatory activation of renal and hepatic gluconeogene-
sis.
TXA2 plays a key role in glycerol—induced acute renal failure in rabbits.
Stegmeier K, Hartig F, Pill J, Patscheke H. Department of Medical
Research, Boehringer Mannheim GmbH, Mannheim and Institute for
Clinical Chemistry, Klinikum Mannheim of the University of
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Heidelberg, 6800 Mann/,ei,n, Federal Republic of Germany. A de-
crease in renal blood flow and constriction of renal vessels has been
reported in glycerol(G)—induced acute renal failure (ARF). In in vitro
experiments an increase of thromboxane A (TXA,), biosynthesis has
been demonstrated in a microsomal preparation from kidney tissue.
This suggests a potential role for TXA2, because of its vasoconstrictory
properties, in this experimental model. We compared the influence of
the new selective TX-antagonist BM 13.505 (BM) with that of the
prostaglandin synthase inhibitor indomethacin (IN) on the development
of glycerol—induced ARF (7 to 8 rabbits/group). ARF was induced by
the s.c. injection of 14 mg/kg G (50% in saline). Five mg/kg BM, or 8
mg/kg IN, or the vehicle only were administered intravenously 30 mm
prior to, and two and six hr subcutaneously, after G-administration.
Twenty—four hr after G-administration an impairment of renal function
was shown by an increase in serum creatinine from 105 to 179
(.tmole/1iter; median). An enhancement in ARF was seen in the G + IN
(3.5-fold rise in serum creatinine). in contrast, in G + BM-treated
animals no change occurred. The histopathological examination of the
kidneys (autopsy at 72 hr after G-administration) revealed that there is
a correlation between the morphological changes (tubular dilations,
casts, tubular necrosis, mononuclear infiltrations of the cells and
interstitial edema or fibrosis) and the extent of impairment of renal
function. The potentiating effect of IN on G-induced ARF has been
previously reported. In contrast, only minimal changes were seen in a
few animals treated with G + BM. Within 24 hr of G-administration the
excretion rate of TXB2, the stable metabolite of TXA was increased
fourfold in G and G + BM-treated groups, and twofold in G + IN
group. These data show that G-induced ARF is accompanied by a
stimulated TX biosynthesis. BM 13.505 prevented the development of
ARF without influencing the TX-synthesis. These results confirm the
key role of TXA2 in this model. IN inhibits the biosynthesis of all
prostaglandins. The enhancement of ARF by IN supports the hypoth-
esis that vasodilating prostaglandins attenuate the pathogenic effect of
TXA2.
Immunodeflciency in the early stage of chronic renal failure. Kurz P.
Meuer S, Weber M, HOtteroth T, Meyer zum Buisehenfrlde KH, Kô/iler
H. Department of internal Medicine, University of Mainz, Federal
Republic of Germany. Pre-uremic patients and patients on chronic
hemodialysis show a diminished immunization rate after active hepatitis
B vaccination. In a previous study we also demonstrated a markedly
reduced immune response in the early stage of chronic renal failure. We
therefore examined the immune status of these patients to determine
the manifestation of the secondary immunodeficiency in the course of
chronic renal failure. Thirty-five patients with different degrees of renal
insufficiency (serum creatinine 1.5 to 9.1 mg/dliter) received 20 tg of
hepatitis B vaccine (H-B VaxR, MSD) i.m. at 0, 1 and 6 monthly
intervals. 19 healthy volunteers (hospital staW) served as controls. The
proliferative responses of peripheral blood lymphocytes (PBL) follow-
ing mitogenic and allogeneic stimulation were examined in a subgroup
of II patients (mean serum creatinine 2.9 mg/dliter). PBL were stimu-
lated with Concanavalin A (Con A), Phytohemagglutinin (PHA),
Pokeweed Mitogen (PWM) and in the Mixed Lymphocyte Culture
(MLC). Blast transformation was determined by 3H-Thymidine uptake
into the DNA of the cells. Only 54% of the patients developed anti-i-lB
antibodies after triple vaccination with hepatitis B vaccine compared to
95% of the control group. There was no difference in the immunization
rate between patients with a mean serum—creatinine of 2.9 (range
I.5—3.5 mgldliter) (N 20) and patients with a mean serum—creatinine
of 6.9 (range 3.6—9.1 mg/dliter)(N = IS). The immunization rates were
55% and 53%, respectively. Compared with the control group, patients
showed a weaker and delayed immune response after hepatitis B
vaccination. The in vitro studies of PBL from II patients with a
serum—creatinine between 1.5 and 3.5 mg/dliter showed a markedly
reduced proliferative response after stimulation with lectins and in the
MLC when compared with healthy controls. The proliferative index
was 5.1 vs. 22.7 in the MLC, 31.2 vs. 85.6 for PHA, 42.8 vs. 55.8 for
Con A and 17.8 vs. 24.7 for PWM. Conclusions: A reduced immune
response to hepatitis B vaccine can be seen already in the early stage of
chronic renal insufficiency, in these patients also, reduced proliferative
responses to lectins and alloantigens were found, indicating that a
defect in the cellular function occurs very early in the development of
renal failure and might account for the secondary immunodeficiency.
immunosuppressive therapy of the nephrotic syndrome in minimal
change nephropathy and in focal segmental glomerulosclerosis with
special reference to 1gM nephropathy. A retrospective study in 55 adults.
Schollmeyer P, Eichin S, Boesken WH, Rohrbach R, Neumann HPH.
Department of Nephro/ogy, University of Freihurg, Federal Republic
of Germany. In a long term follow—up, we studied the therapeutic effect
of prednisolone (P) in combination with cyclophosphamide (CYC) or
chlorambucil (CHL) in the nephrotic syndrome (NS) caused by minimal
change nephropathy (MC) or focal segmental glomerulosclerosis (FS).
The NS was defined by proteinuria  3.0 g/day and serum protein  6.5
g/dliter. The diagnosis of the glomerular lesion was obtained by
histological specimen. Patients with the NS secondary to other diseases
were excluded. Treatment was started by p (1.2 mg/kg/day). If treat-
ment was without effect within two weeks, therapy was continued with
CHL (0.15 to 0.3 mg/kg/day with an upper total limit of 600 mg) and P
(I mg/kg/day) or with CYC (2 mg/kg/day) and P (1 mg/kg/day) for six
weeks. Remission (R) was defined by proteinuria less than I g/day and
partial remission (PR) by proteinuria less than 3 g/day. From 1976 to
1984, 55 patients with the NS caused by MC or FS were seen. Ratio of
male to female was 2:1. Seventeen patients who refused to enter the
study were not treated. From the total of 38 patients treated, eight
received P alone, the other 30 CHL or CYC. The mean time of follow
up was six years. The outcome of therapy is summarized in the table. in
MC all patients were successfully treated, three of them with P alone.
In the group of typical FS (FSb) success was achieved in 35% only. In
a group which appeared to be a transitional form with only minor
lesions but with predominantly 1gM positive immunofluorescence de-
posits (FSa) treatment was successful in 10 out of II patients.
No R/
TOTAL Th PR S
MC 9 I I/O 3
FSa 13 2 1/0 3
FSb 33 14 1/3 2
Th = Therapy; S = Steroids (Prednisolone)
is there clinical evidence for an IgA nephropathy (IgAN) in patients
(pts) with liver cirrhosis (CI)? Brunkhorst R, Groger U, Brunner G,
Koch KM, Bahlmann J, Schedel I, Kuhn K. Hannover Medical School,
West Germany. Elevated serum IgA levels (5-IgA) and mesangial IgA
deposits (MAD) are common findings in alcoholic liver cirrhosis (ACI).
We investigated the clinical evidence for a "secondary" lgAN in 61 pts
with ACI (N = 27) and posthepatic liver cirrhosis (HCI, N = 34) by
examination of total urinary protein excretion (PU), urinary protein
electrophoresis (SDS-UE) and urinary erythrocyte morphology (Ery-
M). Twenty pts without CI and histologically proven IgAN served as
controls (lgA-NC). The following parameters were determined: S-IgA(normal value < 4.5 g/liter), PU, SDS-UE. Ery-M was performed by
phase contrast microscopy (glomerular hematuria > 80% dysmorphic
erythrocytes). S-IgA was elevated in 9 of 34 HCI pts, in 21 of 27 ACI
pts, and in 9 of 20 IgA-NC pts. PU and SDS-UE: Only two ACI pts of
the 61 Cl pts showed a PU > 3 g/day and a pattern of glomerular
proteinuria in UE. 59 pts had a PU < 0.5 g/day and no evidence of a
glomerular pattern in UE. Ery-M: in 20 of 20 pts with lgA-NC > 80%
dysmorphic erythrocytes were found. Only the 2 ACI pts with
pathologic PU and UE had > 80% dysmorphic erythrocytes. 59 Cl pts
had < 80% dysmorphic erythrocytes in the urine. We conclude that in
spite of an often elevated S-igA and a described high incidence of MAD
in Ad, the clinical evidence of a secondary IgAN is unusual.
Effect of mineralocorticoids on &2— and —adrenoceptors and free
intracellular calcium in normotensive man. Fritschka E, LudersdorfM,
Kribben A, Harwig S, Thiede H-M, Hal/er H, Lenz T, Philipp Th,
Distler A. Kliniku,n Steglitz, Free University Berlin, Federal Republic
o,f Germany. The mechanism of the increased peripheral resistance
(TPR) in mineralocorticoid hypertension is still unclear. Alterations of
sympathetic nervous activity and increased passive membrane perme-
ability for sodium have been related to the increase in TPR. In addition,
a decreased density of vascular /32-adrenoceptors has been found in the
R/ CYC/ R/ No
PR CHL PR effect
3/0
3/0
0/0
5 5/0 0
8 7/0 1
17 5/1 II
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DOCA-salt rat, suggesting a decreased capacity for vasodilation. We
therefore studied the effect of chronic application of fludrocortisone (9
a-F) on a2- and 132-adrenoceptors, as well as on intracellular calcium in
normotensive man. Eight men (mean age 24 1 years) received 0.8
mg/day 9 a-F p.o. for six weeks. Blood samples were drawn at 0, 1, 3,
and 6 weeks, as well as 3 weeks after treatment. a2-adrenoceptors were
determined by 3H-yohimbine binding on platelet—membranes. /32-
adrenoceptors were measured on whole lymphocytes with 125I..(+
cyanopindolol. Platelet intracellular calcium (Ca1) was measured by the
Quin2 method. Noradrenaline (NA) was measured by radioenzymeas-
say. The densities of a2-adrenoceptors decreased by week I and
remained subnormal, whereas the densities of J32-receptors decreased
later by week 3 and 6 (Table). KD of 132-receptors decreased, whereas
a2-KD was unchanged. Plasma-NA was suppressed by weeks I to 6. Ca1
increased by week I only. Sodium excretion (UVNa) decreased by
weeks I and 3 (Table). Conclusions. The decreased density of
adrenoceptors may be a reflection of sodium and volume retention and
cannot be explained by increased sympathetic tone, since plasma-NA
was suppressed by 9a-F. Whereas a2-receptor density did not change
during the period of TPR increase (between weeks I and 6), a marked
decrease in 132-receptor density occurred at week 3 and 6, suggesting a
decreased vasodilator capacity, which in turn should result in increased
TPR. Since previous studies demonstrated a normal or subnormal TPR
at week I, the initial increase of Ca, if present also in arteriolar smooth
muscle cells, does not appear to be directly related to the final elevation
of TPR.
control 1 week
MAP, mm Hg
a2-receptor density, fm/mg
prot.
/32-receptor density, fm/mg
prot.
KDaZ-receptors, nM
K0/32-receptors, pM
Ca1, nM
Plasma-NA, pg/mliter
UVN,mmoles/24hr
89
222
60
1.6
42
100
239
150
3
20
3
0.2
5
8
39
17
98 3*
179 18*
64 8
2.0 0.4
22 3*
180 21*
137 11*
112 12*
3 weeks 6 weeks control
MAP,mmHg
a2-receptor density, fm/mg
prot.
132-receptor density, fm/mg
pro:.
Ka2-receptors, nM
Kn/32-receptors, pM
Ca, nM
Plasma-NA, pg/muter
UVNa,mmoles/24hr
97 4*
162 15*
46 4*
1.4 0,2
16 1*
124 14
163 22
133 14*
101 4*
178 14*
43 3*
1.4 0.1
17 2*
122 12
151 18*
144 8
93 2
217 19
60 4
1.6 0.2
35 5
109 3
274 19
158 10
* P < 0.05.
The diagnostic value of erythrocyte morphology in the urine. Roth R,
Brunk B, Weber M, Baum H-P, Kohler H. First Department of Internal
Medicine, and Institute of Pathology, University of Mainz, Mainz,
Federal Republic of Germany. The demonstration of dysmorphic
erythrocytes in the urine has been suggested to be characteristic of
glomerular bleeding. The aim of our study was to determine whether the
examination of urinary erythrocytes by phase—contrast microscopy
might be helpful in distinguishing glomerular from nonglomerular bleed-
ing. In addition, we tested whether the morphology of urinary erythro-
cytes may be helpful to differentiate between various forms of kidney
diseases. The urinary sediments of 145 patients with hematuria who
suffered from various disorders of the kidney or of the urinary tract
(103) were investigated, including patients with histologically—proven
glomerulonephritis (42). According to hematological classifications, the
urinary erythrocytes were classificated by phase-contrast microscopy.
In addition, urinary osmolarity as well as pH and protein concentrations
were investigated. In patients with glomerular bleeding, the erythro-
cytes were more fragmented with an irregularly shaped surface. The
erythrocytes resembled peripheral blood cells such as: torocytes,
stomatocytes, codocytes, knizocytes, acanthocytes and aschizocytes.
The acanthocytes seemed to be the most characteristic form. A mean
value of 12% was found, whereas in nonglomerular bleeding the amount
of acanthocytes was found to be less than 2%. In addition, predom-
inance of dysmorphic cells and poorly hemoglobinized red cells were
found to be characteristic for glomerular bleeding. The demonstration
of echinocytes was of no diagnostic value, because they could be
produced artificially only by using a glass cover slip prior to examina-
tion of the sediment. In 35 out of 42 patients with glomei-ulonephntis, a
correct diagnosis was established by examination of the urinary sedi-
ment alone. Contrary, in 103 patients with hematuria from the urinary
tract, a glomerular bleeding was presumed in 1 case according to
erythrocyte morphology in the urinary sediment. We believe that the
use of phase-contrast microscopy for the examination of the urinary
erythrocyte morphology may be helpful to differentiate between
glomerular and nonglomerular hematuria. Red cell morphology failed to
differentiate between the various nonglomerular lesions or the various
types of glomerulonephritis.
Role of vasopressin in clinical hyponatremia. Gross P, Pehrisch H,
Rascher W, Schomig A, Hackenthal E, Ritz E. Medizin. Klinik,
Kinderklinik, and Pharmakologisches Institut, University of Heidel-
berg, Heidelberg, Federal Republic of Germany. Hyponatremia is a
frequent electrolyte disturbance. Its clinical significance and etiology
are debated. We therefore studied hypo-osmolar hyponatremia (PNa =
127.8 0.6 mM/liter, Posm = 262.2 1.3 mOsm/kg) in 100 unselected
patients in the hospital. We observed characteristic underlying illnesses
to be associated with hyponatremia: 49% of all patients suffered from
congestive cardiac failure or cirrhosis of the liver and all of them
received diuretics; 32% primarily had dehydration and plasma volume
contraction; 10% had SIADH; 9% had advanced renal failure. All four
groups had one abnormality in common which was elevated plasma
vasopressin for the degree of observed hypo-osmolality (PADH = 5.07
0.8 pg/mliter; RIA; detection limit of assay 0.75 pg/muter). This may
therefore be a cause of the hyponatremia, since the average daily fluid
intake was 2.2 liter. Furthermore, physical examination and laboratory
evaluation both suggested nonosmolar, circulatory vasopressin stimuli
to account for the observed ADH concentrations in heart failure,
cirrhosis and volume contraction. These patients had the following
alterations: PRA = 34.4 7.3 ng A1/mliter/hr; norepinephrine 5.28
0.5 nM/liter; aldosterone 46.2 17.1 ng/dliter; C. = 42.2 mliter/min.
All these data were significantly different from normal. Their degree of
abnormality was further shown by comparison with our observations in
SIADH: PRA = 1.2 0.27 (P < 0.05); norepinephrine 2.17 0.4 (P
<0.05); aldosterone 5.5 2.2(P<0.05);Ccr = 102 11.6 (P<0.05).
We conclude that these observations, taken together with the high
in—hospital mortality of 25% in hyponatremic patients with heart
failure, cirrhosis and primary volume contraction, demonstrate that
hyponatremia in these disorders is indicative of advanced circulatory
compromise.
Hypertension with increased iS-hydroxy-corticosterone (18-OH-B) and
adrenal adenoma, a variant of Conn's syndrome. Abdelhamid S, Vecsei
P, Gaca A, John HD, Thoenes W, Rummeny E. Deutsche Klinik f.
Diagnostik, Wiesbaden, Pharmakologisches Institut der Universität
Heidelberg, Pathologisches Institut der Universität Mainz, Germany.
In three cases with Conn's syndrome, urinary 18-OH-B aldosterone-
18-glucuronide (ald-18-gluc), tetrahydro-aldosterone (Th-ald), and free
aldosterone (f-aId) were determined by chromatography and radio-
immunoassay. Plasma cortisol, corticosterone and urinary cortisol were
measured by radioimmunoassay. The results are shown in the Table. In
case 1 (S.A., 36 yr, fern.), renin activity was low, potassium,
plasma—aldosterone (supine: 2,6-6,2-2,5, upright: 5,6-8,4-7,1 ng/I00
muter) (normal 2 to 10), corticosterone, ACTH and urinary DOC were
normal. Urinary 17-OH-corticosteroids were normal to slightly ele-
vated, free cortisol was elevated, however the specificity of the assay is
still in examination. After surgery of the left adrenal adenoma the blood
pressure normalized. In case 2 (HG., 54 yr, fem.) renin activity was
low; potassium, plasma aldosterone (supine: 1,0-3,2, upright: 1,0-5,4
ng/lOO mliter) corticosterone, urinary free cortisol, tetrahydro-corti-
sone, tetrahydro-cortisol, DOC and I 7-OH-corticosteroids were within
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normal range. Normalization of blood pressure was after adrenalec-
tomy. The data of case 3 (M.M., 32 yr, male) are similar to those of case
2. The left adrenal adenoma was visualized. It is possible that as yet
unknown adrenal steroid(s) may participate in the pathogenesis of
hypertension. 18-OH-B possesses alone only minimal biological activ-
ity. Elevated 18-OH-B excretion can be an indicator of an increased
production of biologically active steroids.
18-OH-B
8.7
8.0
6.8
7.0
14.3 8.3
15.3 11.9
7.1 14.9
9.8
11.5 13.9
15.0
Normal 5—25 1.5—6.5 3.5—17.5 10—70 0.08—0.45
range ng/l00 ml
Management of hypertension in unilateral parenchymatous kidney
disease: results of nephrectomy and medical therapy. Wanner C, Liischer
T, Burger HR, Siegenthaler W, Vetter W. Departments of Medicine,
University Hospitals Freiburg, Federal Republic of Germany, and
ZOrich, Switzerland. Unilateral parenchymatous kidney disease asso-
ciated with high blood pressure represents a potentially curable form of
hypertension. Surgery may normalize blood pressure in a substantial
part. We therefore evaluated the curable effect of surgery and medical
therapy and compared both therapeutic approaches. Forty—three pa-
tients (28 female, 15 male; mean age 35.5 13.8 years) were investi-
gated over a mean observation period of 4.3 2.4 years. All 43 patients
were hypertensive (blood pressure > 160 and/or < 95 mm Hg). In 34
patients (79%) a renal arterial disease was excluded by angiography. In
the remaining nine patients, the etiology of the kidney disease was
assessed by intravenous pyelography and laboratory data. Renal ve-
nous renin determinations were performed in 34 patients. Twenty
patients were nephrectomized (group I) and 23 patients were treated
with antihypertensive drugs (group II). Statistical analysis was per-
formed by regression analysis, t-test and x2 test. Both groups showed a
comparable mean age, blood pressure and mean plasma creatinine
values. In 28 of 43 patients (65%), radiological signs consistent with
unilateral pyelonephritis were found. In five patients (12%) unilateral
segmental hypoplasia and in one patient radiation nephritis was diag-
nosed. Nine patients (21%) could not be classified radiologically.
Postoperatively BP fell from 185 27/116 + 13 to 138 + 20/86 10
mm Hg in the operated and from 194 32/116 13 to 149 22/95
12mm Hg in the medically treated patients (P < 0.001). BP was 142
16/89 II and 136 16/90 10 mm Hg at the longterm follow—up in
the two subgroups. In the operated group 70% (N = 14) were cured,
20% (N = 4) were improved and 10% (N = 2) were unimproved. In the
medically treated group 65% (N = 15) were normotensive, 26% (N =
6) improved and 9% (N = 2) treatment resistant. Mean PRA ratio of all
34 patients was 3.7 (1.1—20). In group I mean PRA ratio was signifi-
cantly higher (5.5 5.6) than in group 11(1.9 1.6; P < 0.02).
Sixty—four percent of all patients had significant PRA ratios ( 1.5). No
significant correlation between postoperative blood pressure reduction
and lateralization of renin secretion was found. Although cured patients
showed a higher mean PRA ratio, 4 patients with PRA ratio < 1.5 were
cured (N = 2) or improved (N = 2) postoperatively. Our results
document an excellent and sustained antihypertensive effect of both
nephrectomy and medical treatment in patients with unilateral paren-
chymatous kidney disease and hypertension. They further limit the
predictive value of renal venous renin determination in the preoperative
work—up.
Captopril lowers blood pressure without potentiation of kinins in blood.
Influence of naloxone on head—out water immersion (WI) induced
endocrine alterations in hypertensive patients. Baczynski R, Kokot F.
Department of Nephrology, Silesian School of Medicine, Katowice,
Poland. The present paper aimed to investigate the importance of
opiate receptors on WI induced alterations of plasma renin activity
(PRA), plasma aldosterone (ALD) and AVP in hypertensive patients as
related to the etiology of hypertension. Ten patients with 10 and 15 with
110 (according to the WHO criteria) essential hypertension (EH), 10
patients with renovascular (RVH) and eleven patients with nephritic
hypertension (NH) were examined. The control group consisted of 12
normotensive healthy subjects. Changes in blood volume, PRA, plasma
ALD, AVP and osmolality (Osm) and blood pressure (BP) were
checked before and 120 mm after WI in untreated and naloxone—treated
subjects. WI was followed by a significant and similar increase of
plasma volume and decrease of HP, PRA, ALD, AVP and Osm in all
hypertensive subjects regardless, of the etiology of hypertension.
Pretreatment by naloxone did not change the WI induced endocrine
reaction patterns significantly both in normotensive and hypertensive
subjects. Conclusion: Endogenous opiates do not seem to play a
significant role in WI induced endocrine alterations both in hyperten-
sive and normotensive subjects.
Effect of blood membrane contact during hemodialysis on pulmonary
circulation. Ernst W, Koch KM, Baldamus CA, Schoeppe W.
Universitats— Klinik Frankfurt/M., Med. Hochschule Hannover, Fed-
eral Republic of Germany. The effect of complement activation of
cuprophan' dialyzers on pulmonary hemodynamics is discussed con-
troversially. Whereas Lindsay et al found a significant increase in
pulmonary vascular resistance (PVR) in uremic sheep, this could not be
confirmed by Bergstrom et al in normal human volunteers. To settle this
controversy for hemodialysis (HD) patients, the pulmonary hemody-
namics were studied following extracorporeal blood contact with
cuprophan' and with polysulfone dialyzer membranes. Patient profile
was:N = 6, mean age 47 years, 3 m, 3 f, mean time on HD 53 months,
plasma
Patient cortisol
S.A. 14.2
16.6
15.4
10.1
urinary excretion, pg/day
H.G.
Bonner G, Iwersen D, Schunk U, Kapp Ch, Bbchsler U. Department of
internal Medicine ii, University of Cologne, Ostmerheimer Str. 200,
D-5000 KOln 91, Federal Republic of Germany. Inhibitors of the
angiotensin I converting enzyme (ACE) diminish not only the activity of
the renin—angiotensin system but also enhance the activity of the
kallikrein—kinin systems by inhibiting the activity of the kininase II (K
11). In many recent publications it was discussed that captopril (C) as a
potent ACE inhibitor develops its blood pressure lowering effect by
both mechanisms, reduction in angiotensin II release and increase in
kinin concentration. But only a few studies were performed measuring
A C kinin concentration after captopril with valid kinin assay. Systolic bloodAld-18- luc Th-Al
— pressure (RRs), ACE activity (ACEA; radioassay), kinin concentration
14 4 53 s 0 220 in blood (Ki; BK-RIA), and kininase II activity (Ku; BK-RIA) were
134 526 0230 determined before and 1 hr after oral intake of 50 mg of C in
117 416 0210 normotensives (N; N = 8) and in hypertensives (H; N = 6). Ki and
109 632 0120 RRs/d was measured in 4 H after intravenously injected bradykinin
149 0180 (BK; 0.25 to 2.5 pg/kg). One hr after C RRs was significantly (P <0.01)
108 — 0130 decreased (N: 123.3 3.6 to 115.3 3.1 mm Hg; H: 180.0 12.4 to
51 364 0107 152.0 14.4mm Hg). ACEA was completely inhibited by C (N: 3.4
36 395 0093 1.1 U/liter; H: 3.8 1.2 U/liter). Ki was not changed significantly in
40 525 0113 both groups: N: pre-C 51.2 17.1 and post-C 64.8 22.9 pg/mliter, H:
35 358 009 pre-C 46.2 15.0 and post-C 39.9 17.5 pg/mliter. ACEA wasinhibited about 91.6 2.1% in both groups while KII in the used assay
was inhibited only by 33.8 4.5%. Afteraddition of C in vitro (0.1 mM)
KII was inhibited to the same degree (94.4 1.7%). ACEA and KII
correlated in vivo without C very well with r = 0.95 (P < 0.001). From
the BK injection study it was calculated that marked increases of BK
(100 pg/mliter) were needed to effect a reduction about 22 mm Hg in
mean arterial blood pressure as observed in the hypertensives after C.
The results show that C in pharmacotherapeutic doses lower RR
without enhancement of kinins. Furthermore, very high, unphysiologi-
cal levels of kinins in blood are necessary to lower RR about the same
degree as C does. The in vitro studies indicate that BK has a very high
affinity to ACE/KIl and highest concentrations (0.1 mM) of C are
needed to inhibit inactivation of enhanced concentrations of BK. No
difference in Ki was found between N and H. All results together
indicate, that C lowers RR not by stimulation of kinins but rather by
inhibition of renin.
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clinically without problems. Outcome measures (Swan Ganz catheter,
thermodilution) were: mean pulmonary artery pressure (PA; mm Hg),
pulmonary wedge pressure (PC; mm Hg), cardiac output (CO; liter/mm)
and PVR (dyne sec cm-5). Protocol was: Pre and at 30 mm
extracorporeal circulation (QB: 200 muter/mm) without volume loss
and solute exchange the outcome measures were registered in the same
patients undergoing one HD with a cuprophanR (CF 1500,
TRAVENOL) hollowfiber dialyzer and one with a polysulfone (40,
AMICON) hollow fiber membrane.
Results PA PC CO PVR P
CuprophanR
pre
30 mm
13.8
16.7
8.8
9.3
7.7
7.8
52.2 22.8
78.1 32.8 <0,05
Polysulfone
pre
30 mm
15.1
15.0
8.0
8.5
7.2
8.4
58.8 36.6
65.1 40.7 NS
Following blood contact with a cuprophanR membrane which activates
complement and consequently leads to a drop in peripheral leucocyte
count, pulmonary vascular resistance increases significantly. This does
not occur with polysulfone membranes which do not activate the
complement system.
Enhanced seroconversion rate after hepatitis B vaccination of
hemodialysis patients during zinc substitution. Rawer P, Breidenbach
Th, Willems W, Guumann W, Pabst W, Schütter!e G. Zentrum für
Innere Medizin am Klinikum der Justus Liebig—Universitat GieJien,
Federal Republic of Germany. Thirty—six hemodialysis (HD) patients
having failed to respond to conventional hepatitis B vaccination entered
a prospective controlled study. One group was zinc—substituted via
dialysate (6.12 zmole/liter) for seven weeks, when all patients were
revaccinated. In the treatment group the substitution was then contin-
ued for further seven weeks. The influence of zinc substitution on the
seroconversion rate was evaluated. At the end of the study, 28 patients,
14 without zinc substitution (control group = C) and 14 in the treatment
group (Z) remained for evaluation; exclusions were due to death (2),
transplantation (2), change to home dialysis treatment (2), and refusal of
further zinc treatment (2), respectively. None of the patients showed
HB antibodies during the course of observation, The groups were
comparable as to the procedure of dialysis (3 times 4 hours HD/week),
subnormal initial plasma zinc concentrations, and vaccination status (20
zg of HB VaxR at months 0, I, and 6). Both groups had been matched
with respect to age, sex, underlying kidney disease, and time intervals
to last vaccination. At the seventh week of the trial all patients had still
no detectable HB. antibodies (anti-HB). In the Z group, the mean
plasma zinc concentration (Zn) increased sharply immediately after
HD. In the C group only a moderate increase was observed. After both
the seventh and 14th week of the trial, Zn was significantly higher in the
Z group. At the end of the study, in 9 out of 14 Z group patients
seroconversion occurred (64.3%) in contrast to 5 out of 14 patients(35.7%) in the C group. The anti-HB, titers attained by the
seroconverted patients were distributed similarly in the Z and C groups.
In conclusion, zinc substitution via dialysate over 14 weeks results in a
significant increase in zinc plasma concentration and seems to increase
the rate of seroconversion after hepatitis B vaccination in primary
non-responders.
Enhanced gastrointestinal absorption of aluminum in uremic rats. mel
TH, Buddingion B, Miller NL, Alfrey AC. Department of Medicine II,
University of Aachen, Aachen, Federal Republic of Germany, and
Veterans Administration Medical Center and University of Colorado
School of Medicine, Denver, Colorado, U.S.A. To investigate the
possibility of enhanced gastrointestinal absorption of aluminum in
uremia, we measured the urinary aluminum excretion of rats following
an oral load of 11 mg aluminum. Rats, in which uremia had been
established by the remnant kidney model, excreted 1.5 to 2.2-fold
higher amounts of aluminum in their urine over a collection period of
five days compared with their controls. Within this period of time up to
0.17 0.08% of the applied dose of aluminum was recovered in the
urine of the uremic animals. Serum levels of aluminum were signifi-
cantly elevated five hours after ingestion of aluminum, but this increase
had the same magnitude in rats with normal or reduced renal function.
Uremic rats excreted significantly less aluminum during the first 24 hr
after intravenous administration of 15 g aluminum if the data were
corrected for the higher baseline levels, and the excretion rate showed
a negative correlation with the serum creatinine. Selective
parathyroidectomy had no effect on the pattern or amount of urinary
aluminum excretion after an oral load neither in uremic rats nor in rats
with normal renal function, We conclude that the gastrointestinal
absorption of aluminum is increased in uremic rats, and that parathy-
roid hormone has no detectable effect on the magnitude of aluminum
absorption regardless of the renal function in this model.
Transplantation
Urinary thromboxane B2 in the diagnosis of acute kidney allograft
rejection. Steinhauer HB, Wilms H, Schollmeyer P, Kirste G. Depart-
ments ofNephro!ogy and Surgery, University of Freiburg, Freiburg
j.Br., Federal Republic of Germany. The clinical and laboratory signs of
acute renal allograft rejection are unspecific. It is difficult to differen-
tiate episodes of rejection from acute tubular necrosis (ATN), viral or
bacterial infections, and cyclosporin A (CyA) toxicity. The aim of the
present study was to investigate the value of urinary thromboxane
(TXB2) in the diagnosis of acute kidney transplant rejection. TXB2U
was compared with fractional sodium excretion (FEN), creatinine
clearance (Clj, urinary 132-microglobulin (13MG,,), and body tempera-
ture (T). The study was performed in 106 patients (age 38.5 1.1, range
19 to 59 years) from the day of transplantation till day 14 to 69. Ten
healthy volunteers served as age matched controls. TXB20 was deter-
mined by radioimmunoassay. TXB20 was below 0.40 nglmliter in
healthy volunteers as well as in transplant recipients without signs of
rejection. During 99 episodes of acute rejection observed during the
study, TXB2U increased up to 0.94 0.09nglmliter. The raise of TXB2U
occurred 0.8 0.5 days prior to the clinical diagnosis of rejection. A
strong positive correlation existed between TXB2U and J3MGU (P <
0.001) whereas no correlations were found between FEN,,, Clv, T, and
TXB2U. During ATN, urinary tract infection, and CyA toxicity, TXB2,,
remained within the normal range whereas I3MGU increased signifi-
cantly. The histological diagnosis of acute rejection was confirmed by
elevated TXB2,, in five out of six cases. In further six cases without
histological signs of rejection there was no increase in TXB2,,. Trans-
plant recipients in whom all raises of TXB2U were treated with high dose
steroids were released earlier from hospital care and with better
allograft function (P < 0.05) than patients in whom increases of TXB2U
were treated never or incompletely with high dose steroids. It is
concluded that TXB2U is a more specific marker of acute kidney
allograft rejection in comparison to global and tubular indicators of
renal transplant function.
New morphological findings concerning cyclosporine A nephrotoxicity
in Wistar rats. Fasel J, Kaissling B, Ludwig KS, Ryffel B, Mihatsch MJ.
Institute of Anatomy, Sandoz Ltd., Institute of Pathology, Base!,
Switzerland. Morphological changes in the kidneys of various experi-
mental animals following treatment with cyclosporine A (CSA) have
been described by several authors. The purpose of the present study
was to examine systematically the kidneys of Wistar rats after high CSA
doses at light- and electronmicroscopic level. The animals were given
100 mg CSA/kg/day per os for 12 days. The kidneys were fixed by
retrograde vascular perfusion. In addition to the already described
morphological changes of proximal tubular cells (that is, inclusion
bodies, cytoplasmic vacuolization) the following new observations
were made:
—The parietal layer of Bowman's capsule is markedly thickened, by
cellular hypertrophy and hyperplasia as well as by thickening of the
basal membrane.
—In the segments P2 and P3 of the proximal tubule the epithelial brush
border is partially missing.
—The vacuoles in the segments P2 and P3 originate from the rough
endoplasmic reticulum.
—Degenerative changes have occasionally been observed in smooth
muscle cells of some Aa. interlobulares and Vasa afferentia.
The last finding could indicate the Wistar rat to be a possible animal
model for the vasculopathy described in human.
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Cyclosporine A altered renal tubular cells in urinary cytology.
Winkelmann M, Burrig KF, KoldoL'sky U, Witkowski M, Grabensee B,
Pfizer P. Departments of Medicine, Pathology and Cytopathology,
University of Düsseldorf, Federal Republic of Germany. Despite its
nephrotoxicity, cyclosporine A (Cy A) has become the most important
immunosuppressive drug in renal transplantation. Besides complica-
tions like acute renal failure, CMV infection and acute rejection crisis,
low renal function may be due to Cy A treatment. The main histopath-
ological findings following Cy A therapy are vacuolized cytoplasm,
giant mitochondria and nuclear pycnosis. All these changes should be
found by urinary cytology, too. Urine specimens of 26 patients were
evaluated routinely every day after transplantation. Sediments of
freshly voided urine were prepared by cytocentrifuge and stained by
Papanicolaou and May—Grunwald—Giemsa. Renal tubular cells with
enlarged and extremely vacuolized cytoplasm were found in the urine of
all patients. Monocytic origin of these cells could be excluded by
monoclonal antibodies against macrophages and against epithelial cell
associated antigen (ECAA). The latter showed positive reaction in renal
tissue on tubular structures. In electron micrographs the altered but
sufficiently preserved tubular cells often featured giant mitochondria
containing enlarged matrical granules. By light microscopy these cells
could be easily differentiated from degenerative tubular cells shed under
rejection. The incidence and the number of Cy A altered renal tubular
cells correlated with serum levels of Cy A. In all patients there were 27
episodes of elevated Cy A levels (> 800 ng/mliter). More than five Cy
A altered renal tubular cells were detected in five high power fields in 22
of these cases with elevated Cy A levels. In five episodes the amount of
altered cells was not elevated probably due to polyuric dilution of more
than five liters/day. Increased counts of Cy A deteriorated cells without
elevated Cy A levels were not observed. Though cytological monitoring
of urine specimen cannot replace renal biopsy in general it is a
non-invasive method to differentiate between acute allograft rejection
and deteriorated renal function due to Cy A.
Successful conversion from cyclosporin A (CSA) to azathioprine in
renal allografts with severely impaired function. Frei U, Block T,
Riechers G, Wonigeit K, Ringe B, Pichlmayr R, Koch KM. Depart-
ments of !Vephrology and Transplant Surgery, Hannover Medical
School, Hannover, Federal Republic of Germany. Cyclosporin A has
improved results in kidney transplantation, but acute and chronic CSA
nephrotoxicity remains a problem to be solved. CSA—treated patients
(pts) tend to have elevated serum creatinine levels as compared to pts
with conventional immunosuppression. Since some pts develop pro-
gressive deterioration of graft function, which does not respond to
anti-rejection treatment and CSA dose reduction, we wanted to evalu-
ate whether these pts could benefit from conversion from CSA to
azathioprine treatment. From 1981 to 1984, 224 transplant recipients
were treated with CSA and low dose steroids. The initial CSA dose was
14 mg/kg BW. During the maintenance phase the CSA dosage was
adjusted to obtain whole blood trough levels of 300 to 600 ng/mliter
(RIA). This immunosuppressive regimen was changed in II pts 12.3
months (mean, range 2 to 37) after transplantation to azathioprine 2
mg/kg BW. Criteria for conversion were: a) serum creatinine 250
mole/liter or b) rapid deterioration of graft function or c) biopsy
proven signs of CSA toxicity. During conversion the steroid dose was
increased for three weeks to 0.5 mg/kg prednisolone. One graft was lost
during the observation period of 4 to 17 months (mean 6.5), in 1 case
graft function remained stable, in 2 cases function deteriorated. In the
7 pts with improvement serum creatinine level fell from 483 (range 235
to 734) to 290 (190 to 530) tmole/liter within one month and remained
stable during the observation period. The results indicate that those pts
with rapid deterioration of function in the later post-transplant phase
may benefit from conversion. These pts represent a small subgroup of
CSA treated pts, since the majority treated with CSA and monitored by
blood levels maintained stable graft function.
The influence of cyclosporin A (CS-A) on the subsets and function of
peripheral lymphocytes. Leimenstoll G, Fulde R, Zabel P, Dreyer I,
Niedermeyer W. Department of JVephrology, University of Kid, Kid,
Federal Republic of Germany. The subsets and function of peripheral
blood lymphocytes are of importance in clinical supervision after allogenic
transplantations. On this issue there are many contradictions in medical
literature. This was our reason for exploring if and in what way CS-A
influences the subsets and function of peripheral blood lymphocytes. At 4
hr and 24 hr after a single application of 7.5 mg oral dose of CS-A to seven
patients on dialysis, the peripheral blood lymphocytes (OKT 3, OKT 4,
OKT 8) were monitored using the peroxydase method. The mitogen
stimulated IL-2 production of lymphocytes was monitored by measuring
the proliferation of IL-2 dependent human lymphocytes. The same pa-
tients without medication were part of the control group, as were five
healthy persons. Four hr after the application of CS-A, the OKT 4-fraction
had decreased by 10 to 15%, but the OKT 8-fraction remained constant.
Twenty—four hr after the application of CS-A the subpopulations had
reached their initial levels. There were no differences between the results
of the experimental and the control group. lL-2 production did not show
any diurnal rhythmic and remained constant after the CS-A application
influence peripheral lymphocytes populations neither the function of
T-helper cells. In the supervision after transplantations the time of blood
sampling is of importance so that there are no false resolutions. Currently
we are studying the effects of a prolonged CS-A medication on peripheral
blood lymphocytes.
Differential expression of HLA-DR, -DP, -DQ antigens on human renal
tissue. Muller GA. Risler T, Bockhorn H, Hop! U, Muller GH, Schareck
W, Greger B, Muller C. Medical University Clinics and Surgical Univer-
sity Clinic, 7400 Tubingen, Federal Republic of Germany. In clinical
kidney transplantation graft prognosis depends on the identity between
donors and recipients MHC antigens. In particular, MHC class II antigens
are supposed to play a major role in the induction of immune responses.
Therefore, precise localization of HLA-DP, -DQ and -DR antigens was
investigated in the immunoperoxidase technique on cryostat sections of 20
normal human kidneys and of 12 rejected renal grafts. Serologically and
immunochemically, well characterized monoclonal antibodies directed
against monomorphic determinants of the different HLA-D region antigen
subtypes were applied (TU22: anti-HLA-DQ; TU34: anti-HLA-DR;
TU39: anti-HLA-DR/DP; FA: anti-HLA-DP—subgroup). In all normal
adult kidneys endothelial cells of the glomeruli, capillaries, big arteries and
the interstitial "dendritic" cells reacted positively with the antibodies
TU34 and TU39, indicating the expression of HLA-DR and -DP antigens
on these cells. In addition, proximal tubular cells of all tested kidneys
expressed HLA-DP antigens but not all of them were positive for HLA-
DR antigens. In contrast to the distribution of H LA-DR and -DP antigens
the expression of HLA-DQ antigens was limited to interstitial "dendritic"
cells and to a lower extent to glomerular endothelial cells. Tubular cells
never expressed HLA-DQ antigens. The HLA-DP subgroup antigens,
detected by FA, was found on endothelial cells of glomeruli, capillaries,
whereas the reactivity with endothelial cells of big arteries and with
proximal tubular epithelial cells was rather weak. In rejected kidney
allografts a reduction of HLA-DR and -DQ antigen expression on glomer-
ular endothelial cells was observed, whereas other vascular endothelial
and interstitial "dendritic" cells remained HLA-DR-DP-DQ positive.
Furthermore an increase of HLA-DRJDP antigens on tubular cells was
seen in rejected kidney grafts. Selective and variable expression of MHC
class II antigens in the kidney may be related to different functions on renal
cells during immune responses.
The influence of cyclosporin A on renal function. Investigations in
chronically instrumented conscious dogs. Wagner K, Neumayer HH,
PreuschofL, Schulize G, Offermann G, Molzahn M. Klinikum Steglitz,
Free University Berlin, Federal Republic of Germany. Cyclosporin A
(CyA) is being used as immunosuppressive therapy in organ transplan-
tation and in immune mediated diseases. The mechanism of its major
side effect, its nephrotoxicity, is still unknown. We therefore evaluated
the influence of a short—term infusion (48 hrs) of different doses of CyA
on renal function in chronically instrumented conscious dogs. In four
uninephrectomized Beagle dogs, an electromagnetic flow probe was
placed around the renal artery. In addition, the animals received an
aortic catheter, which was located above the origin of the renal artery.
One week after the instrumentation, the investigations were initiated.
GFR was measured by a single—shot technique using inulin. Urinary
prostanoid excretion was determined by RIA. After evaluation of
baseline parameters, the animals received a 48 hr infusion of CyA in a
dosage of 5—10—20 mg/kg/day.
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Results Control
CyA, mg kg' day'
5 10 20
RBF,mlmin 139 4.6 114 108 132
GFR, m1 mi,r' 35 0.2 39.9 31.4 25.6
PRA, ng ATI h m1' 2.48 0.87 5.81 5.1 5.0
ng mi,r'
CyA level, ng m1'
0.31 0.05
—
0.31
718
0.49
>2000
0.26
>2000
mean, SEM (2428) (7939)
Although the differences were not significant, there was a tendency
toward a decrease in GFR and an increase in PRA. With the highest
dose of CyA, PGE2 excretion was diminished. These findings may
therefore be interpreted as an indication that in the early phase of CyA
administration changes in renal function might be due to a disturbance
of the balance of vasoactive renal hormones.
Familial glomerulopathy with giant fibrillar deposits recurring in a
renal transplant. Reutter FW, Gloor F, Hofmann E. Medical Clinic B
and Institute of Pathology Kantonsspital 9000 St. Gallen, Switzerland.
In 1980 we reported a very unusual form of familial renal disease
characterized by diffuse glomerular lesions with mainly subendothelial,
but frequently transmembranous and mesangial, fibrillar deposits, lead-
ing so far in two of five affected members of one kindred to endstage
renal failure. The nature of the fine to medium—sized granular filamen-
tous deposits is not yet identified, immunofluorescence and special
stains being all inconclusive. All patients show microhematuria and
proteinuna, three are hypertensive and one has a nephrotic syndrome.
Two patients received cadaver transplants. In one, 27 months after
transplantation, a transplant biopsy was performed because of progres-
sive graft failure and heavy proteinuria (creatinine 510 smole/liter, pro-
teinuria 5.3 g/24 hr). In addition of mild acute rejection of tubulointerstitial
type, there were open glomerular tufts with frequent predominantly
subepithelial and occasionally mesangial deposits staining intensively with
PAS. Immunofluorescence was negative for immunoglobulins and compo-
nents of complement. Electron microscopy demonstrated subendothelial
and interstitial deposits of identical structure as seen in two previous
biopsies of the patient's own kidneys. Because of therapy—resistant graft
failure hemodialysis was reassumed 33 months after transplantation. An
unidentified substance formed by the transplant recipient and deposited by
circulation in the kidneys must be postulated as cause of the unique
deposits in this form of familiar nephropathy.
The clinical value of CMV-prophylaxis by CMV-hyperimmunoserum
after kidney transplantation. Greger B, Kurth J, Schareck W, Muller
GH, Hopt UT, Bockhorn H. Chirurgische Universitdtsklinik Tubingen,
Federal Republic of Germany. CMV-infections are a common and
dreadful complication by immunosuppressed patients after kidney
transplantation. Some hyperimmunosera for passive CMV-
infection—prophylaxis are available by now. To study the clinical value
of this rather expensive CMV-hyperimmunoglobulin—prophylaxis we
divided kidney transplantated patients into 4 groups: group 1: patients
immunosuppressed by cyclosporin A and low—dose corticoids; they
received no CMV-hyperimmunoserum—prophylaxis. group 2: im-
munosuppression as in group I, but additional protection of the patients
by CMV-hyperimmunoserum in a dosage of 0.1 g/kg body wt preoper-
atively, the 1st post-operative day and once in every 3 weeks for 1/2
year. group 3: patients treated by ATG-lmurek and low—dose
corticoids. Those patients received no CMV-hyperimmunoserum.
group4: immunosuppression as group 3, but additional CMV-hyperim-
munoserum as group 2. Both cyclosporin-A treated groups had a low
infection incidence about 25%; only 20% of those patients exerted
clinical symptoms without prophylaxis. In contrast, the infection inci-
dence in group 3 was markedly increased (40%); paradoxically the
prophylaxis group 4 had an additional increased infection incidence
with 67% of the patients. In addition these infections were significantly
more severe. Although all infected patients of group 3 also suffered
from clinical symptoms like fever or leucopenia (40%), we registered
66% of clinical symptoms in group 4, which resulted in two
infection—caused losses of transplant and I encephalitis. Although these
results reveal some effect of CMV-immune—prophylaxis with cyclospo-
nfl A therapy, this seems to be contrary in the ATG-Imurek—treated
patients: this can be due to direct interactions between the CMV-
specific hyperimmunoserum and the ATO or immunoregulatory re-
sponses or RHS-exhaustion.
The corpulence—index in cyclosporin A dosage adjustment after kidney
transplantation: lower drug toxicity with effective immunosuppression.
Greger B, Schareck W, MOller GH, Hopt UT, Bockhorn H.
Chirurgische Universitätsklinik Tubingen, Federal Republic of Ger-
many. Examinations on the correlation between the corpulence—index
(Cl) and the cyclosporin A (CsA) dosage after kidney transplantation
revealed the dependence of the course of CsA level—kinetics from the
Cl-index. Patients with a low Cl-index have usually steep serum—level—
kinetic courses with a high Peak—Trough (PIT) index around 5, while
patients with a higher Cl-index exert flat serum—level—kinetics with PIT
indices around 2.5. These serum—level—kinetics seem to depend on the
behaviour of the body fat as 3rd factor in distribution and elimination of
the lipophilic drug. For determination of the effect of those different
serum—level-courses we have examined in 65 steady—state CsA-treated
kidney transplantated patients:
I. The amount of CsA in mg/kg body wt, which those patients require
to maintain the therapeutic serum—levels.
2. The CI, expressed by body wt x 100
tallness — 1003. The CsA dose effectivity, which is expressed by the
serum—level—value per kg/dose.
4. The corticoid requirement per patient in the first 1/2 year after
transplantation.
5. The incidence of rejection crisis.
6. Kind, time-course and severity of cyclosporin A induced drug
toxicity.
While there were no significant Cl—depending differences in corticoid
requirement or rejection incidence, those could be shown for some
toxic manifestations of the drug. Side effects like tremor, paresthesias
or hepatotoxicity were Cl-depending, while other side effects like
gingivahyperplasie or hirsutism showed no significant dependence. In
the post-operative course of the kidney transplantation, a CI determi-
nation and CsA serum level—kinetic should be done in each individual
patient to achieve flat serum—kinetics by adjusting the cyclosporin A
dosage intervals to the individual requirements. Thus one may be able
to lower the PiT index and in addition, the toxicity of the drug.
Treatment of post transplant hyperparathyroidism with APD: a new
biphosphonate. Leunissen KML, van Leendert R, Vismans F, van Hooff
JP. Department of Internal Medicine, St. Annadal Hospital,
Maastricht, The Netherlands. Severe post-transplant hyperpara-
thyroidism is treated always surgically by almost complete removal of
the parathyroid glands. We want to report the medical treatment of
post-transplant hyperparathyroidism with APD (3-amino-l-hydroxy-
propylidene 1. 1-diphosphonate) in two patients. Both patients had
severe bone pain, elevated serum calcium levels and increasing para-
thyroid hormone (PTH 1-84) levels one year after a successful renal
Patient I cyclosporin Patient 2 cyclosporin
After 12 After 12
Baseline weeks Baseline weeks
SEM treatment SEM treatment
Clearance,
mliter/min 45 45 50 50
Calcium,
mmolelliter 2.95 0.05 2.62 2.93 0.05 2.70
N:2. 10—2.65
Parathyroid hor-
mone, pmole
p2/liter 5.61 2.00 1.56 0.92
Ca ¶ : (N < 0.75)
Urinary hydroxy-
proline excre-
tion, nmolel
nmole creati-
nine 62 22 47 19
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transplantation (Table). Vitamin D levels were normal. The bone biopsies
and bone scintigraphies were compatible with hyperparathyroidism. Dur-
ing treatment with APD 150 mg tid, complaints disappeared within one
week, serum calcium levels gradually decreased to near normal levels.
Parathyroid hormone level decreased as well as the urinary
hydroxyproline excretion (Table). Bone biopsies three months after start-
ing therapy showed no further progress of the renal osteodystrophy, as
compared to the biopsies before treatment. There were no adverse
reactions to APD. Recently a third patient with persistent post-transplant
hyperparathyroidism was treated with APD. The same pattern as in the
two patients above was observed: a decrease in serum calcium level and a
60% decrease of the PTH level after one month of treatment. If our
observations are confirmed, treatment of post-transplant hyperpara-
(hyroidism with APD might be an alternative for surgical treatment.
Early cardiovascular rehabilitation after renal transplantation (Tx).
Fro/znert PP. Squires RV, Gau GT, SierioffS, Engen DE, Zincke H.
Mayo Clinic, Rochester, Minnesota, U.S.A. End—stage renal disease
patients are often in poor cardiovascular health due to their prolonged,
debilitating illness with or without hypertension, hyperlipidemia, etc.
Post-transplant recovery may be slowed by the antianabolic effect of
corticosteroids. To accelerate post-transplant recovery safely, we sub-
jected volunteers to a supervised cardiovascular rehabilitation program
early after surgery. A graded exercise test (treadmill) at the beginning
allowed individualized prescription of aerobic exercises. A similar test
was repeated at the end of this program and at subsequent follow—up
visits. Fifteen Tx recipients (M/F: 11/4. age 33 2.2 yrs) commenced
the program 19.0 2.5 days after surgery and attended thrice weekly
for 5.8 0.5 weeks. Each exercise series lasted 25 to 40 mm. The initial
exercise tolerance of 5.7 0.5 METS (multiples of resting metabolism)
increased to 9.2 0.9 METS at termination (P < 0.01) and heart rates
increased from 128 10 beats/mm to 154 6 (P < 0.01). The systolic
blood pressure did not change significantly. Our results show that a
nearly normal exercise capacity can be achieved by the corticosteroid
treated transplant recipient within nine weeks after Tx surgery. This not
only accelerates the recovery process but also establishes positive and
healthy attitudes in these previously debilitated and chronically ill
patients.
